Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

22 events

Tuesday, January 24th: 8:00 - 9:30, Room 1 - Main Arena 1

SYMPOSIUM: New evidence for broadened indications using new generation stents in fempop obstructions

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Andrej Schmidt, Marcus Treitl, Miguel Montero-Baker, Konstantinos Katsanos, Luis Mariano Palena, Yann Gouëffic
1. 08:00 - 08:07
  
  Overview of all available stents for use in the SFA/popliteal arteries
2. 08:07 - 08:14
  
  Stent design matters – results from a single operator registry
3. 08:14 - 08:49
  
  Live case transmission from Leipzig
4. 08:49 - 08:56
  
  Advancing medical care in highly diseased patients – the US experience
5. 08:56 - 09:03
  
  SUPERFAST – a prospective CTOs registry propensity matched with a historical SNS cohort
6. 09:03 - 09:10
  
  The PRESTO technique for precise placement of the SUPERA in the SFA ostium and SUPERSUB update
7. 09:10 - 09:17
  
  CFA stenting experiences to date and insights into the CFA SUPERA study
8. 09:17 - 09:30
  
  Live case transmission from Dendermonde
Tuesday, January 24th: 9:30 - 11:00, Room 1 - Main Arena 1

Drug-eluting devices for prevention of restenosis – the new standard for femoropopliteal interventions in claudicants

Moderator:

Dierk Scheinert, Ramon Varcoe

Panel:

John Laird, Marc Bosiers, Lawrence Garcia, Erich Minar
1. 09:30 - 09:50
  
  DCB CLINICAL TRIAL UPDATE
2. 09:30 - 09:35
  
  Update on 12-month results of the European and US Illumenate RCTs
3. 09:35 - 09:40
  
  2-year results of the AcoArt1 – RCT for the use of the Orchid ® DCB in femoropopliteal artery disease
4. 09:40 - 09:45
  
  Current status of drug coated balloon treatment in the SFA: What do the 3 year outcomes from the IN.PACT SFA RCT tell us?
5. 09:45 - 09:50
  
  A real-world look at treatment effects of IN.PACT Admiral DCB: 12-month results from the IN.PACT Global Study full clinical cohort
6. 09:50 - 09:55
  
  FIRST TIME DATA RELEASE: 6-month results of the RANGER RCT – diabetic subgroup
7. 09:55 - 10:00
  
  FIRST TIME DATA RELEASE: 12-month results from the MDT-2113 SFA Japan trial – DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA
8. 10:00 - 10:05
  
  FIRST TIME DATA RELEASE: DCB: 12-month results of the CONSEQUENT RCT
9. 10:05 - 10:10
  
  FIRST TIME DATA RELEASE: The Lutonix EU Long lesion study
10. 10:10 - 10:15
  
  FIRST TIME DATA RELEASE: 12-month results of the Illumenate Global Study
11. 10:15 - 10:20
  
  FIRST TIME DATA RELEASE: Catheter-mediated deep adventitial microinfusion of dexamethasone for restenosis prevention in femoropopliteal arteries – 12-month results of the DANCE trial
12. 10:20 - 10:25
  
  FIRST TIME DATA RELEASE: 2-year results of the REAL-PTX randomised clinical trial comparing Zilver PTX vs. DCB treatment in femoropopliteal lesions
13. 10:25 - 10:30
  
  2-year data from the MAJESTIC DES trial for treatment of femoropopliteal disease
14. 10:30 - 10:35
  
  DCB + stent in the SFA: 12-month results of the Biolux4ever trial
15. 10:35 - 10:40
  
  Patterns of restenosis: a core lab driven assessment of SFA restenosis a potential shift to unify various trials
16. 10:40 - 10:47
  
  Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease? The REALITY trial
17. 10:47 - 10:54
  
  Are drug-eluting devices the new standard for femoropopliteal interventions in claudication?
18. 10:54 - 11:00
  
  Discussion
Tuesday, January 24th: 11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Drug elution in the SFA: Leave the right thing behind. Debating evidence to provide an answer

supported with a restricted educational grant from Cook Medical

Moderator:

Michael Dake

Panel:

Erwin Blessing, Aloke Finn, Iris Baumgartner
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:15
  
  Why and how to prep the vessel
3. 11:15 - 11:35
  
  Live case transmission from Dendermonde
4. 11:35 - 11:45
  
  Understanding restenosis in the SFA
5. 11:45 - 11:55
  
  The importance of scientific evidence
6. 11:55 - 12:15
  
  Live case transmission from Münster
7. 12:15 - 12:20
  
  Summing up on symposium
8. 12:20 - 12:30
  
  Discussion and debate
Tuesday, January 24th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Tuesday, January 24th: 13:30 - 15:00, Room 1 - Main Arena 1

SYMPOSIUM: Past, present, future: How DCB is enabling treatment of more complex femoropopliteal artery lesions

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert, Krishna Rocha-Singh

Panel:

Thomas Zeller, John Laird, Osamu Iida, Juan Fernando Granada Solis
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Evolution of DCB technology
3. 13:45 - 13:48
  
  Discussion
4. 13:48 - 14:08
  
  Live case transmission from Leipzig
5. 14:08 - 14:18
  
  IN.PACT drug-coated balloon: Consistent clinical outcomes across patient populations
6. 14:18 - 14:21
  
  Discussion
7. 14:21 - 14:31
  
  Gain lumen, maintain patency: The power of adjunctive therapy with directional atherectomy and DCB
8. 14:31 - 14:34
  
  Discussion
9. 14:34 - 14:55
  
  Live case transmission from New York
10. 14:55 - 15:00
  
  Conclusion and summary
Tuesday, January 24th: 15:00 - 16:30, Room 1 - Main Arena 1

SYMPOSIUM: Redefining SFA treatment in a drug-eluting world

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert, Iris Baumgartner

Panel:

Gunnar Tepe, Thomas Zeller, Konstantinos Katsanos
1. 15:00 - 15:03
  
  Introduction and learning objectives
2. 15:03 - 15:15
  
  Drug coated balloons – for all or some?
3. 15:15 - 15:27
  
  Eluvia drug eluting stent: A platform for success?
4. 15:27 - 16:01
  
  Live case transmission from Leipzig
5. 16:01 - 16:13
  
  Getting to answers with clinical trials: being bold
6. 16:13 - 16:25
  
  Why you should care about health economics in PAD: Funding meaningful innovation
7. 16:25 - 16:30
  
  Close and take home learnings
Tuesday, January 24th: 16:30 - 18:00, Room 1 - Main Arena 1

THE LAST FRONTIERS: New concepts for calcified lesions

Moderator:

Chris Metzger, Hiroyoshi Yokoi

Panel:

Marcus Thieme, Gunnar Tepe, Lieven Maene, Thomas Heller, James McKinsey
1. 16:30 - 16:37
  
  Patterns of calcification: intimal vs. medial and differences below and above the knee
2. 16:37 - 16:44
  
  The Shockwave lithoplasty concept – latest results
3. 16:44 - 17:04
  
  Live case transmission from Leipzig
4. 17:04 - 17:11
  
  Importance of thorough vessel preparation followed by anti-restenotic therapy: an update from the DEFINITIVE AR study
5. 17:11 - 17:16
  
  Treatment of challenging calcified lesions with the next generation. Phoenix atherectomy system
6. 17:16 - 17:21
  
  Recorded case
7. 17:21 - 17:28
  
  10 steps to percutaneous bypass of extra long, complex SFA occlusions
8. 17:28 - 17:35
  
  FIRST TIME DATA RELEASE: The DETOUR trial: Six-month outcomes of percutaneous bypass in long segment femoral-popliteal occlusions
9. 17:35 - 17:55
  
  Live case transmission from New York
10. 17:55 - 18:00
  
  Discussion
Wednesday, January 25th: 8:00 - 9:30, Room 1 - Main Arena 1

Optimising outcome of BTK interventions in CLI – Current approaches and future outlook

Moderator:

Dierk Scheinert, Jihad Mustapha

Panel:

Peter Schneider, Ramon Varcoe, Juan Fernando Granada Solis, Osamu Iida, Frank Vermassen, Mohammad AlTwalah
1. 08:00 - 08:10
  
  Live case transmission from Leipzig – part I
2. 08:10 - 08:15
  
  Prognostic impact of revascularisation in poor-risk patients with critical limb ischaemia: The PRIORITY registry
3. 08:15 - 08:21
  
  What have we learned from past DCB BTK studies: Technology, clinical study design, and patient management
4. 08:21 - 08:27
  
  Does paclitaxel interfere with wound healing?
5. 08:27 - 08:33
  
  How do I treat BTK/CLI with DCB: Past experience and a new beginning
6. 08:33 - 08:39
  
  Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug?
7. 08:39 - 08:43
  
  The clinical rationale: Why endpoints for CLI trials should be evaluated at 6 months instead of 1 year
8. 08:43 - 08:49
  
  Alternative methods of drug delivery: The LIMBO trial
9. 08:49 - 09:05
  
  Live case transmission from Leipzig – part II
10. 09:05 - 09:10
  
  Towards optimised BTK results by preventing recoil and sealing dissections – TOBA BTK
11. 09:10 - 09:15
  
  Bioabsorbable scaffolds in BTK arteries: 24-month results from ABSORB BTK
12. 09:15 - 09:20
  
  1-year results in real world patients with ABSORB BTK
13. 09:20 - 09:25
  
  Dealing with calcification in BTK arteries – is lithoplasty the answer?
14. 09:25 - 09:30
  
  Percutanoues deep venous arteriolisation for no-option CLI – 1-year results
Wednesday, January 25th: 9:30 - 11:00, Room 1 - Main Arena 1

SYMPOSIUM: Leading DCB era in China – Current evidence and practice

supported with an educational grant from Acotec

Moderator:

Wei Guo

Panel:

Dierk Scheinert, Weiguo Fu, Zhong Chen, Zhidong Ye, Francesco Liistro
1. 09:30 - 09:39
  
  DCB is changing the treatment paradigm of femoral-popliteal lesions in China
2. 09:39 - 09:48
  
  Orchid DCB in Leipzig – real world experience
3. 09:48 - 09:57
  
  Orchid DCB brings new life to a ISR patient – Story behind 31 month patency
4. 09:57 - 10:06
  
  How did DCB change my treatment principle in femoral-popliteal lesions
5. 10:06 - 10:15
  
  Long DCB in long lesion – benefits for lesions beyond 150mm
6. 10:15 - 10:24
  
  Atherectomy plus DCB: China experience
7. 10:24 - 10:33
  
  DCB in BTK: Preliminary result from Acoart BTK study
8. 10:33 - 10:50
  
  Live case transmission from Leipzig
9. 10:50 - 11:00
  
  Discussion and summary
Wednesday, January 25th: 11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Proven long-term outcomes for complex femoropopliteal lesions

supported with an educational grant from Gore & Associates

Moderator:

Giovanni Torsello

Panel:

Peter Soukas, Takao Ohki, Michel Reijnen, Jorge Fernández Noya
1. 11:00 - 11:05
  
  The endoluminal bypass – What have we learnt so far
2. 11:05 - 11:20
  
  Live case transmission from Münster
3. 11:20 - 11:30
  
  How to achieve good results with Gore Viabahn for treating complex femoropopliteal occlusive disease: Results from the Japanese IDE trial
4. 11:30 - 11:35
  
  Discussion
5. 11:35 - 11:55
  
  Live case transmission from Leipzig
6. 11:55 - 12:05
  
  Dealing with edge stenosis and outcomes of failed endografts
7. 12:05 - 12:10
  
  Discussion
8. 12:10 - 12:20
  
  Best practices in the treatment of TASC C & D lesion of femoro-popliteal district in CLI patient 4-year results
9. 12:20 - 12:30
  
  Discussion and conclusion
Wednesday, January 25th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Wednesday, January 25th: 13:30 - 15:00, Room 1 - Main Arena 1

SYMPOSIUM: Lutonix® Drug Coated Balloon – Evidence in SFA, BTK, and AV

supported with an educational grant from C. R. BARD

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Michael Lichtenberg, Antonio Micari, Scott O. Trerotola
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:43
  
  A study of downstream events of the two leading DCBs on the market
3. 13:43 - 13:50
  
  Lutonix® efficacy in BTK: Results of Lutonix® drug-coated balloons angioplasty in below the knee arteries in critical limb ischemia patients
4. 13:50 - 14:00
  
  Clinical benefits at 12-month from the Lutonix EU long lesion study
5. 14:00 - 14:20
  
  Live case transmission from Leipzig
6. 14:20 - 14:27
  
  An interim look at the Lutonix®DCB Global Real World BTK registry - 6-month outcomes
7. 14:27 - 14:35
  
  A first look at the LUTONIX® Catheter IDE clinical trial demographics, lesion, and procedural variables in AV fistula
8. 14:35 - 14:45
  
  Lutonix® efficacy in AV: On-going PAVE study
9. 14:45 - 15:00
  
  Conclusion and FAQ
Wednesday, January 25th: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: DCBs – Where we are and where do we need to be?

Moderator:

Michael Dake

Panel:

Krishna Rocha-Singh, Lawrence Garcia, Saher Sabri, Peter Schneider
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Career Award 2016
2. 15:05 - 15:13
  
  DCB Potential beyond the selected SFA lesion types studied in trials to date: What we know about the real world
3. 15:13 - 15:39
  
  Live case transmission from Columbus
4. 15:39 - 15:47
  
  Current views on vessel prep prior to DCB – pre-dil, atherectomy, etc., what we’ve learned
5. 15:47 - 15:55
  
  Current status of DCB experience with non-femoropopliteal applications (dialysis, tibial, venous, etc.)
6. 15:55 - 16:22
  
  Live case transmission from Columbus
7. 16:22 - 16:30
  
  DCB and restenosis; who fails and why: What we do about it now and what the future holds
Wednesday, January 25th: 16:30 - 18:00, Room 1 - Main Arena 1

New concepts for complex femoropopliteal disease

Moderator:

Marc Bosiers, Takao Ohki

Panel:

Sabine Steiner, Dong-Hoon Choi, Ralf Langhoff, Antonio Micari, James McKinsey, Osamu Iida
1. 16:30 - 16:36
  
  2-year outcomes from the DEB-SFA-Long Study
2. 16:36 - 16:42
  
  Tack-optimised angioplasty (TOBA) – Update on latest data and current projects
3. 16:42 - 16:48
  
  6-month results of the LOCOMOTIVE registry investigating spot stenting in the femoropopliteal tract
4. 16:48 - 16:54
  
  The MIMICS-2 IDE study: interim update on BioMimics 3D in US, Japan, and Europe
5. 16:54 - 17:14
  
  Live case transmission from Leipzig
6. 17:14 - 17:20
  
  FIRST TIME DATA RELEASE: 2-year results of the VIABAHN Japan IDE trial for complex SFA lesions
7. 17:20 - 17:26
  
  FIRST TIME DATA RELEASE: 3-year results of ZEPHYR (ZilvEr PTX for tHe Femoral ArterY and Proximal Popliteal ArteRy) study
8. 17:26 - 17:48
  
  Live case transmission from Columbus
9. 17:48 - 17:54
  
  Comparing endoluminal bypass to open fempop bypasses: Final 1-year results of the SUPERB trial
10. 17:54 - 18:00
  
  Surgical bypass vs. ZilverPTX stent for long SFA lesions: Interim results of the Zilverpass trial
Thursday, January 26th: 8:00 - 9:30, Room 1 - Main Arena 1

THE LAST FRONTIERS: Complex tibial and below-the-ankle interventions

Moderator:

Jihad Mustapha, Roberto Ferraresi

Panel:

Frank Vermassen, Michael Edmonds, Keisuke Hirano, Steven Kum, Sigrid Nikol
1. 08:00 - 08:25
  
  Live case transmission from Leipzig
2. 08:25 - 08:32
  
  Angiosome revascularisation strategies in real world practice: how much difference does it make?
3. 08:32 - 08:39
  
  Retrograde tibial puncture has changed the algorithm for crossing tibial lesions in CLI: How and when to do It?
4. 08:39 - 08:46
  
  A systematic review of results with the retrograde tibial approach
5. 08:46 - 09:11
  
  Live case transmission from Abano Terme
6. 09:11 - 09:18
  
  When is below-the-ankle angioplasty indicated and how to introduce it into your practice
7. 09:18 - 09:25
  
  Aggressive below-the-ankle intervention: Its effect on long term outcome
8. 09:25 - 09:30
  
  Discussion and conclusion
Thursday, January 26th: 9:30 - 11:00, Room 1 - Main Arena 1

SYMPOSIUM: Built on evidence: Stellarex DCB technology and clinical program

supported with an educational grant from Spectranetics

Moderator:

Sean Lyden

Panel:

Marianne Brodmann, Stephan Duda, Henrik Schröder, Giovanni Torsello, Michael Lichtenberg
1. 09:30 - 09:38
  
  4 trials/1.000+ patients: results from the ILLUMENATE SFA program
2. 09:38 - 09:58
  
  Live case transmission from Bad Krozingen
3. 09:58 - 10:06
  
  Stellarex evidence in diabetics
4. 10:06 - 10:12
  
  Stellarex evidence in females
5. 10:12 - 10:18
  
  Role of vessel preparation in contemporary DCB practice
6. 10:18 - 10:55
  
  Live case transmission from Leipzig
7. 10:55 - 11:00
  
  Discussion and conclusion
Thursday, January 26th: 11:00 - 12:30, Room 1 - Main Arena 1

Glimpse into the future: New treatment approaches and technologies for peripheral arterial disease

Moderator:

William Gray, Marianne Brodmann

Panel:

Andrew Holden, George Adams, Bob Smouse, Stephan Duda, Andrej Erglis
1. 11:00 - 11:06
  
  Clinical outcomes and magnetic resonance angiography assessment of a new dual component vascular stent
2. 11:06 - 11:12
  
  Design principles of the BioMimics 3D stent and why it's ideal for fempop intervention
3. 11:12 - 11:17
  
  Real world experience with BioMimics 3D, the swirling flow stent
4. 11:17 - 11:36
  
  Live case transmission from Bad Krozingen
5. 11:36 - 11:41
  
  FIRST TIME DATA RELEASE: Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of femoropopliteal lesions
6. 11:41 - 11:47
  
  Direct micropuncture mediated deep adventitial drug delivery – New insights from the DANCE project and future prospects
7. 11:47 - 11:53
  
  Percutaneous bypass with the DETOUR procedure: Using the femoral vein as a natural conduit ... In situ with a twist!
8. 11:53 - 12:18
  
  Live case transmission from Münster
9. 12:18 - 12:24
  
  New evidence review for OCT guided atherectomy: Long term patency, in-stent restenosis, and zero contrast/fluoroscopy in CKD patients
10. 12:24 - 12:30
  
  Future of OCT guided technologies for PAD: True lumen measurement, BTK platform, and calcium therapies
Thursday, January 26th: 12:30 - 13:25, Room 1 - Main Arena 1

LUNCH SYMPOSIUM: Live case with Dr. Andrej Schmidt: Sophisticated CLI access and crossing techniques

supported with a restricted educational grant from Cook Medical

Moderator:

Craig Walker

Panel:

Roberto Ferraresi, Flavio Airoldi, Miguel Montero-Baker

live with:

Andrej Schmidt
Thursday, January 26th: 13:30 - 15:00, Room 1 - Main Arena 1

Treatment of complex aortoiliac disease: Latest techniques and results

Moderator:

Hans Krankenberg, Patrick Peeters

Panel:

Peter Goverde, Frank Vermassen, Gustavo Oderich, Peter Soukas, Patrice Mwipatayi
1. 13:30 - 13:55
  
  Live case transmission from Leipzig
2. 13:55 - 14:02
  
  Outcomes of polytetrafluoroethylene-covered stent in the primary treatment of severe iliac artery obstructive lesions
3. 14:02 - 14:09
  
  Endovascular treatment of severe TASC C and D external iliac artery occlusive disease
4. 14:09 - 14:16
  
  Final results of the BOLSTER study: A prospective, multicenter study of a balloon-expandable ePTFE-covered stent for obstructive lesions in the iliac artery
5. 14:16 - 14:23
  
  Covered endovascular reconstruction of the aortic bifurcation (CERAB) as treatment of extensive aortoiliac occlusive disease: 3-year results
6. 14:23 - 14:48
  
  Live case transmission from Bad Krozingen
7. 14:48 - 15:00
  
  Discussion
Thursday, January 26th: 15:00 - 16:30, Room 1 - Main Arena 1

Challenges and new concepts in hemodialysis access and upper extremity interventions

Moderator:

Andrew Holden, Stephan Duda

Panel:

Konstantinos Katsanos, Daniela Branzan, Roberto Ferraresi
1. 15:00 - 15:07
  
  Strategy and technical tips in treating AV fistulas
2. 15:07 - 15:22
  
  Review of clinical evidence: The role of DCB for the treatment of failing dialysis access stenosis
3. 15:22 - 15:27
  
  FIRST TIME DATA RELEASE: 6-month results of the Lutonix US IDE trial for treatment of AV-fistula obstructions in HD patients
4. 15:27 - 15:34
  
  Technical aspects for treating AV fistulae with IN.PACT DCB
5. 15:34 - 15:39
  
  Endovascular treatment for central venous obstruction in hemodialysis patients
6. 15:39 - 16:06
  
  Live case transmission from Münster
7. 16:06 - 16:13
  
  Shifting the paradigm for dialysis access: The latest everlinQ endoAVF clinical experience and technology evolution – T. Steinke
8. 16:13 - 16:20
  
  What is the true cause of critical hand ischaemia? Results in a large cohort of hemodialysis patients
9. 16:20 - 16:27
  
  Thrombolytic therapy of distal upper extremity occlusions (hypothenar hammer syndrome): A therapeutic option for a rare disease
10. 16:27 - 16:30
  
  Discussion
Thursday, January 26th: 16:30 - 18:00, Room 1 - Main Arena 1

THE LAST FRONTIERS: Interventional treatment of common femoral and popliteal artery disease

Moderator:

Lawrence Garcia, Marc Bosiers

Panel:

Bob Smouse, Sven Seifert, Torsten Fuß, Yann Gouëffic, Chris Metzger, Wei Liang
1. 16:30 - 16:37
  
  The common femoral artery – an anatomical region still reserved for treatment by the surgeons?
2. 16:37 - 16:44
  
  Stenting of the common femoral artery for atherosclerotic lesions: is it feasible and how and when we do it
3. 16:44 - 17:08
  
  Live case transmission from Bad Krozingen
4. 17:08 - 17:15
  
  A randomized comparison of endovascular versus surgery treatment of common femoral artery disease: Results from the TECCO trial
5. 17:15 - 17:22
  
  First experiences in the VMI-CFA study: investigating the Supera stent in the common femoral artery. Is the Supera a valuable alternative for common femoral endarterectomy?
6. 17:22 - 17:46
  
  Live case transmission from Leipzig
7. 17:46 - 17:53
  
  DCB for popliteal artery stenosis: The IN.PACT Flexion trial
8. 17:53 - 18:00
  
  Directional atherectomy plus DCB versus DCB alone for isolated lesions of the popliteal artery
Friday, January 27th: 9:00 - 12:30, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting

Moderator:

Martin Malina, Marc van Sambeek

Panel:

Eric Verhoeven, Thomas Larzon, Piotr Kasprzak, Karin Brachmann
1. 09:00 - 09:40
  
  Live case transmission from Münster
2. 09:40 - 09:47
  
  Endovascular and hybrid approach in the treatment of aberrant subclavian artery and its aneurysm
3. 09:47 - 09:54
  
  In patients with a ruptured it is justified to push the borders of anatomical suitability
4. 09:54 - 10:01
  
  Infected stentgrafts and aneurysms of the aorta: Endovascular repair offers lower early mortality and similar long term results as open repair
5. 10:01 - 10:08
  
  Infective complications after TEVAR: Incidence and treatment options
6. 10:08 - 10:45
  
  Live case transmission from Leipzig
7. 10:45 - 10:52
  
  Association between polycystic kidney disease and aortic aneurysm, presentation of case report and literature review
8. 10:52 - 10:59
  
  Impact of iliac arteries anatomy on the outcome of FB – EVAR
9. 10:59 - 11:06
  
  Retroperitioneal access to target arteries: a bail-out procedure when prograde branch catheterisation does not work for F/B EVAR
10. 11:06 - 11:46
  
  Live case transmission from Münster
11. 11:46 - 12:30
  
  Discussion and conclusion

Room 2 - Main Arena 2

19 events

Tuesday, January 24th: 8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis

Moderator:

Iris Baumgartner, Michael Lichtenberg

Panel:

Christian Erbel, Rolf Engelberger
1. 08:00 - 08:10
  
  Are we ready for a paradigm shift for treating acute DVT
2. 08:10 - 08:30
  
  Live case transmission from Bern
3. 08:30 - 08:40
  
  Single session therapy: Pharmacomechanical thrombolysis to treat acute iliofemoral DVT
4. 08:40 - 08:50
  
  Dual session therapy: Catheter-directed thrombolysis to treat acute iliofemoral DVT
5. 08:50 - 09:00
  
  Duration of anticoagulation therapy post stenting for acute iliofemoral DVT
6. 09:00 - 09:10
  
  Update on VTE consensus guidelines?
7. 09:10 - 09:30
  
  Live case transmission from Galway
Tuesday, January 24th: 9:30 - 11:00, Room 2 - Main Arena 2

SYMPOSIUM: The therapeutic benefit of effective debulking in arteries and veins

supported with an educational grant from Straub Medical

Moderator:

Thomas Zeller, Marcus Treitl

Panel:

Thomas Heller, Miroslav Bulvas, Steven Kum
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:45
  
  Why do I use mechanical debulking for the treatment of arterial occlusions?
3. 09:45 - 10:10
  
  Live case transmission from Leipzig
4. 10:10 - 10:20
  
  How do I use mechanical debulking for the treatment of arterial occlusions
5. 10:20 - 10:30
  
  How do I use mechanical debulking for the treatment of acute occlusions of the proximal veins?
6. 10:30 - 10:55
  
  Live case transmission from Münster
7. 10:55 - 11:00
  
  Discussion and conclusion
Tuesday, January 24th: 11:00 - 12:30, Room 2 - Main Arena 2

Venous stenting

Moderator:

Houman Jalaie, Stephen Black

Panel:

Rick de Graaf, Michael Lichtenberg, Rolf Engelberger
1. 11:00 - 11:15
  
  Live case transmission from Bern
2. 11:15 - 11:30
  
  Live case transmission from Galway
3. 11:30 - 11:40
  
  Patency rates and clinical results of a dedicated ring-design stent for the treatment of iliac vein lesions
4. 11:40 - 11:50
  
  Patency rates and clinical results of a dedicated closed-cell design stent for the treatment of iliac vein lesions
5. 11:50 - 12:00
  
  Patency rates and clinical results of a dedicated May Thurner stent
6. 12:00 - 12:15
  
  Live case transmission from Bern
7. 12:15 - 12:30
  
  Live case transmission from Galway
Tuesday, January 24th: 12:35 - 13:20, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Venous stenting – why, when, and how?

supported with an educational grant from Medtronic

Moderator:

Stephen Black

Panel:

Rick de Graaf, Erin Murphy
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:50
  
  Venous stenting – clinical presentation – why?
3. 12:50 - 13:00
  
  Importance of stent and clinical study design for venous disease – when?
4. 13:00 - 13:10
  
  Imaging to optimise outcomes in venous stenting – how?
5. 13:10 - 13:20
  
  Discussion and summary
Tuesday, January 24th: 13:30 - 15:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular therapy of chronic deep vein obstructions

live from Bern:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Rolf Engelberger, Rick de Graaf

Panel:

Olivier Hartung, Houman Jalaie
1. 13:45 - 13:51
  
  Flash presentation: Difficult IVC filter retrieval: tips & tricks
2. 14:15 - 14:21
  
  Flash presentation: Complex iliocaval reconstructions
3. 14:45 - 14:51
  
  Flash presentation: Hybrid procedures for the management of deep vein obstructions
Tuesday, January 24th: 15:00 - 16:30, Room 2 - Main Arena 2

SYMPOSIUM: Micromesh CAS – patient oriented technology

supported with an educational grant from Terumo

Moderator:

Marco Roffi

Panel:

Giovanni Nano, Stefan Müller-Hülsbeck
1. 15:00 - 15:10
  
  Roadsaver – innovative solutions for CAS
2. 15:10 - 15:35
  
  Live case transmission from Münster
3. 15:35 - 15:45
  
  Are new advancements in endovascular CAS technology impacting our daily practice?
4. 15:45 - 15:55
  
  Micromesh technology in carotid artery treatment – what is next?
5. 15:55 - 16:20
  
  Live case transmission from Cotignola
6. 16:20 - 16:30
  
  Discussion and conclusion
Tuesday, January 24th: 16:30 - 18:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular treatment of central venous stenosis of the chest

live from Bern:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Stephen Black, Andrew Holden

Panel:

René Aschenbach, Wei Liang
1. 16:30 - 16:36
  
  Flash presentation: Treatment of upper extremity deep vein thrombosis due to venous thoracic outlet syndrome
2. 17:00 - 17:06
  
  Flash presentation: Treatment of central venous stenosis in patients with dialysis shunts
3. 17:30 - 17:36
  
  Flash presentation: Treatment of compression-related central venous stenosis in patients with cancer
Wednesday, January 25th: 8:00 - 9:30, Room 2 - Main Arena 2

Current status and open questions in EVAR

Moderator:

Frank Veith, Vicente Riambau

Panel:

Giovanni Torsello, Roger Greenhalgh, Marc van Sambeek, Sebastian Debus, Takao Ohki, Frans Moll
1. 08:00 - 08:07
  
  Lessons learned in 15 years after EVAR trials
2. 08:07 - 08:14
  
  Long term results of EVAR for AAA , are the RCT results still valid?
3. 08:14 - 08:21
  
  Treatment of AAA in Germany: Outcomes, long term results, and trends from German health care data in a 5 year period
4. 08:21 - 08:28
  
  Operating below AAA threshold of 5.5 cm saves lives!!
5. 08:28 - 08:35
  
  Are female patients under-represented in EVAR trials?
6. 08:35 - 08:42
  
  Mechanical characterisation of abdominal aortic aneurysm, using 4D ultrasound
7. 08:42 - 08:49
  
  Cancer rates in patients undergoing endovascular and open repair of AAA
8. 08:49 - 09:15
  
  Live case transmission from Münster
9. 09:15 - 09:30
  
  DEVICE PARADE: LATEST DATA AND DESIGN IMPROVEMENTS FOR ABDOMINAL STENT-GRAFTS
10. 09:15 - 09:20
  
  Long term durability results with the Excluder C3 Endoprosthesis in over 4.000 patients: A comparison of GREAT registry and the Italian GORE Excluder registry
11. 09:20 - 09:25
  
  3-year results of the Ovation PMR registry
12. 09:25 - 09:30
  
  Early experience with the new Bolton TREO abdominal stent-graft
Wednesday, January 25th: 9:30 - 11:15, Room 2 - Main Arena 2

THE REMAINING CHALLENGE: Juxtarenal aneurysms with short and angulated proximal neck

Moderator:

Giovanni Torsello, Frank Criado

Panel:

Piotr Kasprzak, James McKinsey, Thomas Larzon, Sven Seifert, Wolfgang Ritter
1. 09:30 - 09:37
  
  The evolution of the aortic neck after EVAR
2. 09:37 - 09:44
  
  How are long-term EVAR outcomes impacted by extremely hostile necks
3. 09:44 - 09:51
  
  Practicing outside of IFU – also an issue with new sac filling technologies?
4. 09:51 - 09:58
  
  Open vs. FEVAR for pararenal aneurysms: a propensity adjusted comparison
5. 09:58 - 10:23
  
  Live case transmission from Leipzig
6. 10:23 - 10:30
  
  Custom EVAR (c-EVAR) a step in between standard EVAR and FEVAR
7. 10:30 - 10:37
  
  Home-made versus regular fEVAR for juxtarenal AAA
8. 10:37 - 10:44
  
  Long-term results of endoanchors in minimizing EVAR failures (Type 1A endoleaks and migration) in hostile aortic necks: update from the ANCHOR registry
9. 10:44 - 10:53
  
  Recorded case: Endoanchors
10. 10:53 - 11:00
  
  EVAS with parallel grafts for challenging neck anatomy – results from the ASCEND registry
11. 11:00 - 11:15
  
  Recorded case: EVAS with Chimney grafts
Wednesday, January 25th: 11:15 - 12:30, Room 2 - Main Arena 2

Endovascular solutions for iliac aneurysms

Moderator:

Piergiorgio Cao, Armando Lobato

Panel:

Spiridon Botsios, Eric Verhoeven, Ralph-Ingo Rückert, Fabio Verzini, Andrea Stella, Reza Ghotbi
1. 11:15 - 11:22
  
  Long term results of iliac branch endografting: lessons learnt in 10 years
2. 11:22 - 11:29
  
  Experience and long term results of ePTFE iliac branched device
3. 11:29 - 11:36
  
  Bilateral IBD for aorto-iliac aneurysms: technique and results
4. 11:36 - 12:04
  
  Live case transmission from Lille
5. 12:04 - 12:11
  
  Parallel graft techniques for the iliac landing zone
6. 12:11 - 12:18
  
  EVAS for treatment of AAA with concomitant iliac artery aneurysm
7. 12:18 - 12:25
  
  Diameter indications for elective repair of hypogastric artery aneurysms: A current review
8. 12:25 - 12:30
  
  Discussion and conclusion
Wednesday, January 25th: 12:30 - 13:30, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Optimising aneurysm sealing outcomes

supported with an educational grant from Endologix

Moderator:

Ian Loftus

Panel:

Jan MM Heyligers, Claude Mialhe, Michel Reijnen, Patrick Berg
1. 12:30 - 12:40
  
  Influence of patient selection and IFU compliance on outcomes following EVAS
2. 12:40 - 12:55
  
  Nellix procedure
3. 12:55 - 13:05
  
  Type Ia endoleak after Nellix EVAS: Incidence, mechanism, and treatment options: What we’ve learned
4. 13:05 - 13:15
  
  Potential reduction in post implant syndrome following total aneurysm sac sealing with Nellix
5. 13:15 - 13:30
  
  Discussion
Wednesday, January 25th: 13:30 - 15:00, Room 2 - Main Arena 2

SYMPOSIUM: How the hybrid OR changed my life

partially supported with an educational grant from GE Healthcare and Siemens Healthcare

Moderator:

Dittmar Böckler, Gustavo Oderich

Panel:

Giasemi Koutouzi, Koen Deloose, Nuno Dias, Eric Verhoeven, Adrien Hertault, Bernhard Meyer
1. 13:30 - 13:45
  
  Golden rules to reduce radiation dose in the hybrid room to a minimum
2. 13:45 - 13:55
  
  How to potentiate the effects of fusion imaging with extra low dose fluoroscopy and CO2
3. 13:55 - 14:05
  
  Should intra procedural 3D assessment be a standard for EVAR?
4. 14:05 - 14:15
  
  FEVAR tips and tricks: From sizing to CBCT assessment
5. 14:15 - 14:30
  
  How fusion imaging changed my workflow for FEVAR (case in a box)
6. 14:30 - 14:40
  
  When a stab in the back works: Translumbar Type 2 endoleak embolisation
7. 14:40 - 14:50
  
  Next generation imaging for EVAR
8. 14:50 - 15:00
  
  How advanced imaging tools facilitate peripheral occlusion recanalisation?
Wednesday, January 25th: 15:00 - 16:30, Room 2 - Main Arena 2

CX@LINC: Life after EVAR 1

Moderator:

Roger Greenhalgh

Panel:

Ian Loftus, Hence Verhagen, Frans Moll, Frank Vermassen, Martin Malina, Dittmar Böckler
1. 15:00 - 15:10
  
  The benefits of EVAR are age dependent: lessons from long-term outcomes in the UK
2. 15:10 - 15:15
  
  Discussion
3. 15:15 - 15:25
  
  Durability beats low profile
4. 15:25 - 15:35
  
  Make the aortic wall strong and rupture-proof
5. 15:35 - 15:45
  
  Discussion
6. 15:45 - 15:55
  
  EVAR remains first choice in all patients with suitable anatomy
7. 15:55 - 16:05
  
  Frequency of follow-up after EVAR
8. 16:05 - 16:15
  
  The value of open repair for some patients reappears
9. 16:15 - 16:30
  
  Discussion
Wednesday, January 25th: 16:30 - 18:00, Room 2 - Main Arena 2

Endoleak management, pitfalls and complications of EVAR

Moderator:

Andrew Holden, Giovanni Torsello

Panel:

Eric Ducasse, Tilo Kölbel, Thomas Larzon, Olaf Richter, Patrick Kelly, Spiridon Botsios
1. 16:30 - 16:37
  
  The fate of unexpected events occurring during EVAR
2. 16:37 - 16:44
  
  Mid-term results of endoanchoring for the treatment of intraoperative Type Ia endoleak after EVAR in patients with short infrarenal neck
3. 16:44 - 16:51
  
  FEVAR and BEVAR after failed EVAR
4. 16:51 - 16:58
  
  Endoleak management after EVAS – Lessons learned
5. 16:58 - 17:05
  
  Type IA endoleaks after Ch-EVAR: "Achilles heel, Damocles sword" or benign phenomenon in the majority of the cases? Insights from the PERICLES registry
6. 17:05 - 17:32
  
  Live case transmission from Münster
7. 17:32 - 17:39
  
  Breaking down the myth: The data that supports the clinical significance of Type II Endoleak
8. 17:39 - 17:46
  
  The arsenal AAA sac filling system for EVAR: How does it work? What is its value?
9. 17:46 - 17:53
  
  The approach to sac enlargement without evident endoleak
10. 17:53 - 18:00
  
  Transcaval embolisation of endoleaks after EVAR. Technique and tips
Thursday, January 26th: 8:00 - 11:00, Room 2 - Main Arena 2

Latest techniques for endovascular repair of aortic aneurysms and dissections in the thoracic aorta and the arch

Moderator:

Martin Malina, Piergiorgio Cao

Panel:

Matt Thompson, Mario Lachat, Frank Veith, Hervé Rousseau, Weiguo Fu, Martin Misfeld
1. 08:00 - 09:23
  
  CONTROVERSIES IN THE MANAGEMENT OF THORACIC AORTIC PATHOLOGIES
2. 08:00 - 08:06
  
  Is there a way to predict the risk in uncomplicated Type B aortic dissections?
3. 08:06 - 08:12
  
  In most uncomplicated Type B aortic dissection patients TEVAR leads to false lumen thrombosis and stability
4. 08:12 - 08:18
  
  Highlights from the ESVS guidelines for the management of aortic Type B dissection
5. 08:18 - 08:24
  
  Bovine arch and the outcome for acute dissection; is it dangerous?
6. 08:24 - 08:30
  
  Technical tips and tricks for successful treatment of aortic dissections
7. 08:30 - 08:36
  
  Management of intramural hematoma and penetrating ulcers – what is different?
8. 08:36 - 08:42
  
  Uptake of 18F-FDG: new predictor for Type B IMH progression
9. 08:42 - 08:48
  
  Aneurysms and dissections in Marfan and degenerative
10. 08:48 - 09:23
  
  Live case transmission from Leipzig
11. 09:23 - 09:47
  
  DEVICE PARADE: DESIGN IMPROVEMENTS FOR THORACIC STENT-GRAFTS
12. 09:23 - 09:29
  
  Conformability of new generation TEVAR device: Is there a difference?
13. 09:29 - 09:35
  
  The new Valiant EVO device for TEVAR: What makes it better?
14. 09:35 - 09:41
  
  Performance of the conformable GORE TAG device across multiple indications: follow up and outcomes on more than 800 patients
15. 09:41 - 09:47
  
  Relay thoracic stent-graft FDA phase II clinical trial
16. 09:47 - 11:00
  
  INNOVATIVE SOLUTIONS FOR AORTIC ARCH PATHOLOGIES AND BEYOND
17. 09:47 - 09:53
  
  Full surgical repair of the aortic arch – what is best practice?
18. 09:53 - 09:59
  
  Cervical debranching for endovascular arch repair – results, tips, and tricks
19. 09:59 - 10:06
  
  Chimneys and parallel grafts for arch repair: Current review of best indications and techniques
20. 10:06 - 10:12
  
  Aortic arch repair with Bolton RelayBranch stentgraft system
21. 10:12 - 10:18
  
  In situ fenestration for arch reconstruction: Chinese experience
22. 10:18 - 10:24
  
  Nexus aortic arch stentgraft: Mid-term results
23. 10:24 - 10:30
  
  Endovascular solution for pathologies of the ascending aorta: What is on the horizon?
24. 10:30 - 10:55
  
  Live case transmission from Bad Krozingen
25. 10:55 - 11:00
  
  Discussion
Thursday, January 26th: 11:00 - 12:00, Room 2 - Main Arena 2

Expanding endovascular capabilities: Proven solutions for enhanced durability

supported with an educational grant from Gore & Associates

Moderator:

Marc van Sambeek

Panel:

Michel Reijnen, Dittmar Böckler, Robert Rhee, Gustavo Oderich
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:15
  
  GORE® EXCLUDER® AAA endoprosthesis demonstrates long-term durability
3. 11:15 - 11:25
  
  Going the distance: Conformable GORE® TAG® device demonstrates durable TEVAR outcomes over the long-term
4. 11:25 - 11:35
  
  Challenges with complex anatomies: Advancing care in endovascular treatment
5. 11:35 - 11:45
  
  New horizon in endovascular care: early experience with an innovative branched devices
6. 11:45 - 12:00
  
  Discussion and conclusion
Thursday, January 26th: 12:30 - 13:30, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Ovation: Access more patients and customise each seal

supported with an educational grant from Endologix

Moderator:

Dierk Scheinert

Panel:

Matthias Tenholt, Venkatesh Ramaiah, Martin Storck, Andrew Holden
1. 12:30 - 12:40
  
  Mid-term outcomes of the Ovation abdominal stent-graft system for endovascular aneurysm repair
2. 12:40 - 12:50
  
  Fast-track: Results from the Prospective LIFE registry
3. 12:50 - 13:00
  
  EVAR in female anatomy: The gender registry
4. 13:00 - 13:20
  
  Ovation ALTO procedure
5. 13:20 - 13:30
  
  Discussion
Thursday, January 26th: 13:30 - 15:00, Room 2 - Main Arena 2

SYMPOSIUM: Strategies, devices, and techniques to optimise solutions for endovascular aortic repair

supported with an educational grant from Medtronic

Moderator:

Fabio Verzini

Panel:

Giovanni Torsello, Dittmar Böckler, Hence Verhagen, Vicente Riambau, Konstantinos Donas, Mario Lachat
1. 13:30 - 13:38
  
  When can standard EVAR be safely and durably performed in patients with challenging anatomies
2. 13:38 - 14:03
  
  Live case transmission from Münster
3. 14:03 - 14:11
  
  Endoanchors in practice – clinical applications and techniques for success
4. 14:11 - 14:19
  
  Insights from the PROTAGORAS/PERICLES registries: impact on chEVAR results through standardisation of patient selection, devices and techniques.
5. 14:19 - 14:27
  
  ChEVAR in practice – clinical application and techniques for success
6. 14:27 - 14:50
  
  Live case transmission from Münster
7. 14:50 - 15:00
  
  Panel discussion: EVAR, EVAR + EndoAnchor, or chEVAR: When does it make sense to utilise these techniques to optimise outcomes in complex EVAR?
Thursday, January 26th: 15:00 - 18:00, Room 2 - Main Arena 2

THE LAST FRONTIERS: Remaining challenges in TEVAR and pioneering solutions for thoracoabdominal aneurysms

Moderator:

Marc van Sambeek, Giovanni Torsello

Panel:

Armando Lobato, Patrick Kelly, Eric Verhoeven, Martin Malina, Ralf Kolvenbach, Martin Misfeld
1. 15:00 - 16:05
  
  REMAINING CHALLENGES AND NEW SOLUTIONS IN TEVAR
2. 15:00 - 15:07
  
  Upward (cranial) migration of thoracic endografts: Etiology and how to prevent it and treat
3. 15:07 - 15:14
  
  Value of LSA branch devices in clinical practice – early experience with the Valiant MonaLSA device
4. 15:14 - 15:21
  
  The role of air-embolisation for stroke in TEVAR and how to prevent it by CO2-flushing
5. 15:21 - 15:28
  
  Recurrent operations after TEVAR: Incidence, tips and tricks, and results
6. 15:28 - 16:05
  
  Live case transmission from Lille
7. 16:05 - 18:00
  
  ENDOVASCULAR VS. OPEN REPAIR OF THORACOABDOMINAL ANEURYSMS
8. 16:05 - 16:12
  
  Thoracoabdominal aortic aneurysms open repair: Updated multimodal approach
9. 16:12 - 16:19
  
  Comparison of open surgery, hybrid techniques, and F/branched endograft for thoracoabdominal aneurysm
10. 16:19 - 16:26
  
  Valiant TAAA device from Medtronic: Based on a manifold principle with multiple branches to visceral, renal, and iliac arteries: Concept and early results with a potentially OTS device
11. 16:26 - 16:33
  
  Implantation of fenestrated Anaconda™ custom AAA graft system (video)
12. 16:33 - 16:40
  
  Fenestrated Anaconda™: Experience in 101 cases in the UK
13. 16:40 - 16:47
  
  Parallel grafts (snorkels, chimneys) in endovascular TAAA-repair: techniques, results, and current indications
14. 16:47 - 16:54
  
  Treatment of chronic dissections with fenestrated and branched endografts
15. 16:54 - 17:32
  
  Live case transmission from Münster
16. 17:32 - 17:39
  
  TEVAR and distal septostomy in chronic dissection – a new approach in selected patients with descending aorta aneurysm
17. 17:39 - 17:46
  
  Direct false lumen occlusion techniques in chronic TBAD. Update on techniques and results
18. 17:46 - 17:53
  
  What is the benefit of MEP's in branched EVAR for TAAA in preventing paraplegia?
19. 17:53 - 18:00
  
  Ischaemic preconditioning by selective lumbar coiling prior to EVAR for prevention of paraplegia – Initial clinical experience

Room 3 - Technical Forum

19 events

Tuesday, January 24th: 9:00 - 10:45, Room 3 - Technical Forum

DEEP DIVE SESSION: Current status of carotid revascularisation – Part I Focus on scientific data and latest technical innovations

Moderator:

Marco Roffi, Frank Veith

Panel:

Martin Storck, Stanislaw Bartus, Alison Halliday, Carlo Setacci
1. 09:00 - 09:07
  
  Update on the German carotid registry CAS/CEA and future outlook
2. 09:07 - 09:14
  
  Carotid artery stenting: current randomised evidence and future perspectives
3. 09:14 - 09:21
  
  Predictors of periprocedural outcomes of carotid artery stenting: Real world experience
4. 09:21 - 09:28
  
  Despite level 1 evidence to the contrary, the future outlook for carotid stenting is bright
5. 09:28 - 09:53
  
  Live case transmission from Cotignola
6. 09:53 - 10:45
  
  LATEST TECHNICAL IMPROVEMENTS IN CAROTID STENTING AND CEREBRAL PROTECTION
7. 09:53 - 10:00
  
  ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?
8. 10:00 - 10:07
  
  Carotid stenting: closed cell design versus dual layer design – are there any differences in clinical outcome?
9. 10:07 - 10:14
  
  6-month results in 100 patients treated with the Road-Saver stent: The CLEAR-ROAD study
10. 10:14 - 10:21
  
  Comparison of different dual layer stent designs
11. 10:21 - 10:28
  
  Proximal protection for CAS – the superior concept?
12. 10:28 - 10:35
  
  Carotid artery stenting with double filtration using a post-dilation balloon with integrated embolic protection: final results of the PALADIN registry
13. 10:35 - 10:42
  
  A renaissance for CAS? Will new carotid stents and advanced protection concepts fill the gap with CEA?
14. 10:42 - 10:45
  
  Discussion
Tuesday, January 24th: 10:45 - 12:30, Room 3 - Technical Forum

DEEP DIVE SESSION: Current status of carotid revascularisation – Part II Revascularisation in specific disease states

Moderator:

Steve Ramee, Stephan Duda

Panel:

Stanislaw Bartus, Karl-Titus Hoffmann, Horst Sievert, William Gray
1. 10:45 - 11:45
  
  CAROTID REVASCULARISATION IN SPECIFIC DISEASE STATES
2. 10:45 - 10:52
  
  The volume of cerebral ischaemic lesion predicts the outcome after symptomatic carotid revascularisation
3. 10:52 - 10:59
  
  Endovascular treatment of carotid artery aneurysms
4. 10:59 - 11:06
  
  ACST-2 trial update
5. 11:06 - 11:13
  
  Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work
6. 11:13 - 11:20
  
  Will guidelines and clinical practice regarding asymptomatic carotid stenosis change in the near future?
7. 11:20 - 11:45
  
  Live case transmission from Berlin
8. 11:45 - 12:30
  
  FOCUS ON REVASCULARISATION IN ACUTE STROKE
9. 11:45 - 11:55
  
  Interventional stroke treatment – fundamental trials and methods
10. 11:55 - 12:02
  
  Acute stroke interventions: What I learned during my initial cases
11. 12:02 - 12:09
  
  Intracranial thrombectomy – board certification in Germany
12. 12:09 - 12:30
  
  Discussion
Tuesday, January 24th: 12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: Management of arterial and venous occlusive diseases with vacuum assisted mechanical thrombectomy

supported with an educational grant from Penumbra

Moderator:

Theodosios Bisdas

Panel:

Alexander Maßmann, Lorenzo Paolo Moramarco
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:50
  
  Endovascular mechanical thrombectomy in arterial and venous cases: Our experience with the Indigo system
3. 12:50 - 13:00
  
  Intraoperative near infra-red spectroscopy (NIRS) monitoring in lower limb revascularisation of outcome, using the Indigo system
4. 13:00 - 13:10
  
  Peripheral clot management and pulmonary embolism
5. 13:10 - 13:20
  
  Discussion
Tuesday, January 24th: 13:30 - 15:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Challenging femoro-popliteal lesions

live from Leipzig:

Andrej Schmidt

live from Cotignola:

Antonio Micari

Moderator:

Brian DeRubertis, Giancarlo Biamino

Panel:

Erwin Blessing, Matthias Ulrich, Hiroyoshi Yokoi, Baixi Zhuang
1. 14:00 - 14:06
  
  Flash presentation: Crossing techniques for challenging femoropopliteal CTO’s – How I do it
2. 14:15 - 14:21
  
  Flash presentation: The value of the retrograde femoral access for recanalisation and stenting of challenging CTOs
3. 14:30 - 14:36
  
  Flash presentation: How can re-entry devices be helpful in complex recanalisation procedures
Tuesday, January 24th: 15:00 - 16:30, Room 3 - Technical Forum

SYMPOSIUM: Angioplasty, now what? Evidence based lower limb treatment strategies

supported with an educational grant from BIOTRONIK

Moderator:

Jos van den Berg

Panel:

Marianne Brodmann, Patrice Mwipatayi
1. 15:00 - 15:03
  
  Evidence based SFA treatment algorithms
2. 15:03 - 15:10
  
  Is there a future for SFA BMS?
3. 15:10 - 15:40
  
  Live case transmission from Berlin
4. 15:40 - 15:49
  
  Leaving the right thing behind
5. 15:49 - 16:19
  
  Live case transmission from Dendermonde
6. 16:19 - 16:30
  
  REACT to the vessel response – treatment options backed by evidence
Tuesday, January 24th: 16:30 - 18:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Carotid interventions

live from Leipzig:

Andrej Schmidt

live from Cotignola:

Fausto Castriota

Moderator:

Steve Ramee, Horst Sievert

Panel:

Martin Storck, Marco Roffi, Stanislaw Bartus, Zoran Milosevic
1. 16:30 - 16:36
  
  Flash presentation: Carotid stenting – how to properly select suitable patients
2. 17:00 - 17:06
  
  Flash presentation: Integrated embolic protection technology – a new paradigm in the treatment of cardiovascular disease
3. 17:30 - 17:36
  
  Flash presentation: Is there any future for carotid stenting? Proximal protection and mesh-covered stents are the answer
Wednesday, January 25th: 8:00 - 9:30, Room 3 - Technical Forum

Interventional radiological techniques in the hepatic and splenic circulation

Moderator:

Thomas J. Vogl, Ulf Teichgräber

Panel:

Tim Ole Petersen, Boris Radeleff, Peter Huppert
1. 08:00 - 08:07
  
  Hepatic superselective chemoembolisation: conventional TACE vs. drug eluting beads
2. 08:07 - 08:27
  
  Live case transmission from Jena
3. 08:27 - 08:34
  
  Selective internal radiotherapy: what is new?
4. 08:34 - 08:41
  
  Chemosaturation: Indication, technique, and outcome
5. 08:41 - 09:02
  
  Live case transmission from Leipzig
6. 09:02 - 09:09
  
  Combination of transarterial and percutaneous ablation techniques
7. 09:09 - 09:16
  
  New horizons for embolisation treatment in the splenic circulation
8. 09:16 - 09:23
  
  Tips and tricks for TIPPS
9. 09:23 - 09:30
  
  Discussion
Wednesday, January 25th: 9:30 - 11:00, Room 3 - Technical Forum

SYMPOSIUM: Emerging embolisation therapies

supported with an educational grant from Medtronic

Moderator:

Marcus Treitl

Panel:

Nuno Dias, Ian McCafferty, Hans Lindgren
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:47
  
  Miniaturisation of plugs: How does it advance the embolisation practice? Clinical applications presented through real world case study presentations.
3. 09:47 - 09:59
  
  Changing treatment paradigms with soft detachable fibered coils
4. 09:59 - 10:10
  
  Treatment of hypervascular tumors with liquid embolics
5. 10:10 - 10:20
  
  Tips and tricks for treating endoleaks
6. 10:20 - 10:50
  
  Live case transmission from Münster
7. 10:50 - 11:00
  
  Panel discussion
Wednesday, January 25th: 11:00 - 12:30, Room 3 - Technical Forum

Embolisation therapy for visceral aneurysms, bleeding, and beyond

Moderator:

Ulf Teichgräber

Panel:

Thomas Rand, Boris Radeleff, Thomas J. Vogl
1. 11:00 - 11:07
  
  Endovascular techniques for treatment of visceral aneurysms
2. 11:07 - 11:14
  
  Prostate arterial embolization in benign prostate hyperplasia
3. 11:14 - 11:34
  
  Live case transmission from Jena
4. 11:34 - 11:41
  
  Uterine embolisation: techniques and outcome
5. 11:41 - 11:48
  
  Venous embolisation for patients with pelvic congestion syndrome
6. 11:48 - 12:08
  
  Live case transmission from Leipzig
7. 12:08 - 12:15
  
  Emergency embolisation for acute trauma-induced bleeding
8. 12:15 - 12:22
  
  Transcatheter embolisation in upper GI tract arterial bleeding
9. 12:22 - 12:30
  
  Discussion
Wednesday, January 25th: 12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: The experts' approaches to venous intervention

supported with a restricted educational grant from Cook Medical

Moderator:

Rick de Graaf

Panel:

Stephen Black, Gerard O'Sullivan
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:55
  
  Recanalisation techniques and essential tools for venous intervention
3. 12:55 - 13:10
  
  Iliofemoral acute DVT: A pathway to treatment
4. 13:10 - 13:20
  
  Questions and answers
Wednesday, January 25th: 13:30 - 15:00, Room 3 - Technical Forum

VIVA@LINC: Contemporary approaches to CLI challenges

Moderator:

Sean Lyden

Panel:

John Laird, William Gray, Krishna Rocha-Singh, Chris Metzger
1. 13:30 - 14:00
  
  Live case transmission from Columbus
2. 14:00 - 14:05
  
  Flash presentation: How do I determine the minimum necessary end point of an endovascular CLI procedure – when is enough?
3. 14:05 - 14:10
  
  Flash presentation: The present status of self-expanding and balloon-expandable tibial BMS and DES for CLI: Why and when to use
4. 14:10 - 14:30
  
  Live case transmission from Columbus
5. 14:30 - 14:35
  
  Flash presentation: The current role and limitations of below the knee DCB: What we know now
6. 14:35 - 14:40
  
  Flash presentation: Evolving approaches to accurately determine the adequacy of revascularisation in CLI patients
7. 14:40 - 15:00
  
  Live case transmission from Columbus
Wednesday, January 25th: 15:00 - 16:30, Room 3 - Technical Forum

The next evolution for TIPS. Control diameter. Target pressure.

supported with an educational grant from Gore & Associates

Moderator:

Maria Schoder

Panel:

Kerstin Rosenqvist, Jonel Trebicka
1. 15:00 - 15:05
  
  Introduction
2. 15:05 - 15:20
  
  Results of a Swedish TIPS Registry, insights in effects of TIPS offered to patients with variceal bleeding
3. 15:20 - 15:25
  
  Discussion
4. 15:25 - 15:40
  
  First results of the new GORE TIPS Set to deliver the GORE® VIATORR® TIPS Endoprosthesis
5. 15:40 - 15:45
  
  Discussion
6. 15:45 - 16:05
  
  Case based discussion: what you need to know about TIPS
7. 16:05 - 16:15
  
  Initial experience using the new GORE® VIATORR® TIPS Endoprosthesis with controlled expansion for patients with refractory ascites
8. 16:15 - 16:30
  
  Discussion and conclusion
Wednesday, January 25th: 16:30 - 18:00, Room 3 - Technical Forum

THE REMAINING CHALLENGE: Management of recurrent lesions after PTA and stenting

Moderator:

Craig Walker, Giancarlo Biamino

Panel:

Jörn Balzer, Lawrence Garcia, Matthew Menard, Bruno Freitas, Hans Krankenberg
1. 16:30 - 16:36
  
  Repetetive DCB treatment for femoropopliteal lesions – a viable solution for recurrent lesions?
2. 16:36 - 16:42
  
  Plaque scoring and DCB: rationale and initial evidence in SFA-ISR
3. 16:42 - 17:13
  
  Live case transmission from Leipzig
4. 17:13 - 17:18
  
  FIRST TIME DATA RELEASE: 12-month outcomes from the Lutonix ISR randomised trial
5. 17:18 - 17:23
  
  FIRST TIME DATA RELEASE: DCB for ISR: 2-year results of the Copa Cabana Study
6. 17:23 - 17:29
  
  The role of photoablation and DCB for in-stent restenosis
7. 17:29 - 17:35
  
  Brachytherapy for in-stent restnosis – Is the concept still alive?
8. 17:35 - 18:00
  
  Live case transmission from Jena
Thursday, January 26th: 8:00 - 9:30, Room 3 - Technical Forum

CLI and CTO summit – complex aorto-iliac disease

live from Bad Krozingen:

Thomas Zeller

live from Münster:

Arne Schwindt

Moderator:

Michael Dake, Thomas Rand

Panel:

Lieven Maene, Claudio Rabbia, Gustavo Oderich
1. 08:30 - 08:35
  
  Bare metal or nitinol stents for the iliacs: Results of the randomised ICE trial
2. 09:00 - 09:05
  
  Hybrid procedures for complex vessel anatomies
3. 09:15 - 09:20
  
  2D Perfusion imaging to assess the result of BTK interventions
Thursday, January 26th: 9:30 - 11:30, Room 3 - Technical Forum

CLI and CTO summit – complex BTK and BTA disease

live from Abano Terme:

Marco Manzi

live from Leipzig:

Andrej Schmidt

Moderator:

Osamu Iida, Giancarlo Biamino

Panel:

Jihad Mustapha, Roberto Ferraresi, Dai-Do Do, Francesco Liistro
1. 09:45 - 09:50
  
  Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do It?
2. 10:05 - 10:10
  
  PRIME registry data: Value of ultrasound guided access in complex CLI procedures
3. 10:25 - 10:30
  
  In-foot treatment: What not to do! Clinical experience
4. 10:45 - 10:50
  
  Current meta-analysis comparison between DCB and POBA in below-the-knee therapy
5. 11:05 - 11:10
  
  New DCB for BTK treatment: The fight is back! Preliminary data of two randomised trials with DCB vs. PTA in patients with CLI undergoing tibials revascularisation.
Thursday, January 26th: 11:30 - 12:30, Room 3 - Technical Forum

Evolutions in vessel closure – experiences with percutaneous access and closure

supported with an educational grant from Abbott Vascular

Moderator:

Giovanni Pratesi, Venkatesh Ramaiah

Panel:

Wouter Lansink, Bruno Freitas, Bastiaan Vierhout
1. 11:30 - 11:35
  
  Introduction
2. 11:35 - 11:45
  
  Predictors for good outcomes in large hole access and closure
3. 11:45 - 11:55
  
  Smaller profile devices in EVAR and TEVAR. How do they change practice?
4. 11:55 - 12:05
  
  The Leipzig PEVAR experience
5. 12:05 - 12:15
  
  The LIFE registry demonstrates: PEVAR is the way to go with small profile devices
6. 12:15 - 12:25
  
  Piero trial – randomised comparison of open access to PEVAR in 140 patients
7. 12:25 - 12:30
  
  Summary and conclusion
Thursday, January 26th: 12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: Penumbra advancements in embolisation technologies and innovative techniques for carotid revascularisation

supported with an educational grant from Penumbra

Moderator:

Lorenzo Paolo Moramarco

Panel:

Ian McCafferty, Piotr Musialek
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:50
  
  Ruby, POD, and POD packing coil: A game changer in the paradigm of peripheral treatment with new embolisation tools?
3. 12:50 - 13:00
  
  New frontiers in embolisation technology: Ruby, POD packing coil and lantern
4. 13:00 - 13:10
  
  CGuard embolic prevention system (EPS) – routine use in carotid revascularisation for stroke prevention: Accumulating clinical evidence
5. 13:10 - 13:20
  
  Discussion
Thursday, January 26th: 13:30 - 17:00, Room 3 - Technical Forum

“The very sick patient” – Patient oriented approaches in severe critical limb ischemia, renal failure, and beyond – with live case transmissions from Bad Krozingen, Abono Terme, and Leipzig

live with:

Andrej Schmidt, Thomas Zeller, Marco Manzi

Moderator:

Ramon Varcoe, Sigrid Nikol

Panel:

Steven Kum, Erwin Blessing, Hiroshi Ando, René Aschenbach, Miguel Montero-Baker
1. 13:30 - 13:35
  
  Arterialisation of the venous system of the foot in no-option CLI patients: a hybrid (open + endo) approach
2. 13:35 - 13:40
  
  The Limflow procedure for venous arteriolisation – a case based review
3. 13:40 - 13:45
  
  The Limflow video presentation
4. 14:00 - 14:05
  
  Carbon dioxide angiography and angioplasty reduces contrast-induced nephropathy and acute kidney injury
5. 14:05 - 14:10
  
  Feasibility of CO2-angiography for EVAR in patients with chronic kidney disease
6. 14:10 - 14:15
  
  Ultrasound guided revascularisation of complex peripheral obstructions
7. 14:45 - 14:50
  
  Is duplex ultrasound better than angiography to predict target vessel failure/success after DCB in BTK intervention?
8. 14:50 - 14:55
  
  Impact of chronic renal failure on safety and effectiveness of paclitaxel-eluting stents for femoropopliteal artery disease: 24-month results from the Zilver PTX post-market surveillance study in Japan – Y. Ogawa
9. 15:30 - 15:35
  
  Cell and gene therapy for CLI: Update on current evidence and ongoing projects
10. 15:35 - 15:45
  
  A cost analysis comparing endovascular and surgical options for patients with critical limb ischaemia
Friday, January 27th: 9:00 - 12:30, Room 3 - Technical Forum

“Great saves and big disasters” – Review of challenging cases and complications

Moderator:

Giancarlo Biamino

Panel:

Lawrence Garcia, Steven Kum, Roberto Ferraresi
1. 09:00 - 09:05
  
  Announcement of the winners of the LINC 2017 poster award
2. 09:05 - 09:45
  
  Live case transmission from Leipzig
3. 09:45 - 09:52
  
  Chimney technique combined with aortoiliac stenting for the treatment of juxtarenal aortoiliac occlusive disease – V. Suwanruangsri
4. 09:52 - 09:59
  
  Catastrophic iliac ruptur during aorto-iliac angioplasty – M. T. Esfahani
5. 09:59 - 10:06
  
  Use of a percutaneous puncture needle for true lumen re-entry during subintimal recanalisation of the superficial femoral artery – A. Aborahama
6. 10:06 - 10:13
  
  Revascularisation of a popliteal artery chronic total occlusion with concomitant occlusion of all native below-the-knee vessels by implantation of a helical nitinol stent into a single collateral connecting to the dorsal pedal artery – M. Planert
7. 10:13 - 11:07
  
  Live case transmission from Leipzig
8. 11:07 - 11:14
  
  A novel flow-preserving carotid shunt system for carotid endarterectomy – D. M. Oztas
9. 11:14 - 11:21
  
  Hybrid transcarotid direct stenting: How to reach the carotid plaque when there's no access – S. Peralta
10. 11:21 - 12:30
  
  Live case transmission from Leipzig

Room 4 - Discussion Forum

13 events

Tuesday, January 24th: 12:30 - 13:30, Room 4 - Discussion Forum

My idea on intimal tracking: Guide wire selection for Pop-BTK treatment

supported with an educational grant from Asahi Intecc

Moderator:

Jos van den Berg
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:43
  
  My experience in Austria
3. 12:43 - 12:51
  
  My experience in Italy
4. 12:51 - 12:59
  
  My experience in Japan
5. 12:59 - 13:19
  
  Discussion
6. 13:19 - 13:30
  
  Closing remarks by the moderator
Tuesday, January 24th: 13:30 - 14:30, Room 4 - Discussion Forum

Conform to the anatomy rather than altering it

supported with an educational grant from Gore & Associates

Moderator:

Eric Verhoeven
1. 13:30 - 13:35
  
  Challenging anatomies and device conformability: does it matter?
2. 13:35 - 13:45
  
  How to deal with complex popliteal lesions?
3. 13:45 - 13:55
  
  Endovascular repair of popliteal aneurysms
4. 13:55 - 14:05
  
  Endovascular treatment of TASC C & D lesion in Iliac obstructive disease
5. 14:05 - 14:15
  
  An alternative treatment option for calcified lesions in the common iliac artery
6. 14:15 - 14:30
  
  Discussion and conclusion
Tuesday, January 24th: 15:00 - 16:00, Room 4 - Discussion Forum

How do we prevent complications in challenging thoracic anatomies? A physician panel’s take on optimal treatment approaches

supported with an educational grant from Gore & Associates

Moderator:

Dittmar Böckler
1. 15:00 - 15:07
  
  What have we learned after two decades of TEVAR treatment in Type B dissection?
2. 15:07 - 15:14
  
  Optimising access in TEVAR patients
3. 15:14 - 15:21
  
  Preventing strokes in TEVAR: What factors should be considered?
4. 15:21 - 15:28
  
  Planning for a durable future: Factors to consider when treating TEVAR patients
Wednesday, January 25th: 10:00 - 11:00, Room 4 - Discussion Forum

Internal iliac artery preservation: The standard of care when treating iliac aneurysms

supported with an educational grant from Gore & Associates

Moderator:

Gustavo Oderich
1. 10:00 - 10:05
  
  Introduction
2. 10:05 - 10:13
  
  The GORE® EXCLUDER® iliac branch endoprosthesis: Feasibility and utility to preserve internal iliac arteries
3. 10:13 - 10:21
  
  Conformability is key in treating complex iliac anatomies
4. 10:21 - 10:29
  
  How effective is preservation when viewed through a clinical and economic lens?
5. 10:29 - 11:00
  
  Discussion and conclusion
Wednesday, January 25th: 11:15 - 12:15, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – triumph or tragedy

Moderator:

Peter Schneider

Discussant:

Michael Dake, Sean Lyden, Antonio Micari, John Laird
1. 11:15 - 12:15
  
  This is a case-based session focusing on what we like best...real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.
Wednesday, January 25th: 12:30 - 13:30, Room 4 - Discussion Forum

Pelvic congestion syndrome: How and when to treat with embolisation techniques

supported with an educational grant from Medtronic

Moderator:

Kathleen Gibson
1. 12:30 - 12:40
  
  PCS disease state, diagnosis & treatment challenges
2. 12:40 - 12:50
  
  PCS case presentation & discussion
3. 12:50 - 13:00
  
  PCS: The gynecologist's perspective
4. 13:00 - 13:30
  
  Discussion
Wednesday, January 25th: 13:45 - 14:45, Room 4 - Discussion Forum

CICE@LINC - Acute venous occlusive disease - Mechanical debulking as the first therapy option

Moderator:

Armando Lobato
1. 13:45 - 13:53
  
  Step by step of mechanical thrombectomy in venous occlusive disease
2. 13:53 - 14:01
  
  Why is mechanical debulking the logical treatment option?
3. 14:01 - 14:09
  
  Recanalisation of venous occlusions with AspirexS mechanical thrombectomy – the effective one session treatment, wich largely replaces the need of thrombolysis
4. 14:09 - 14:17
  
  Complex cases with mechanical thrombectomy system in venous disease
5. 14:17 - 14:45
  
  Panel discussion
Wednesday, January 25th: 15:00 - 16:00, Room 4 - Discussion Forum

SITE@LINC: AORTIC endografting: what is needed for a definitive consolidation

Moderator:

Vicente Riambau

Discussant:

Eric Verhoeven, Nilo Mosquera, Jorge Fernández Noya, Gustavo Oderich
1. 15:00 - 15:05
  
  Introduction
2. 15:05 - 16:00
  
  TOPICS TO BE DISCUSSED: What are the major limitations for endovascular repair of para and supra-renal aneurysms? What TEVAR needs to be considered for all Type B dissections? What are the major limitations for endovascular repair of para and supra-renal aneurysms? Is centralization needed for EVAR/TEVAR?
Thursday, January 26th: 10:00 - 11:00, Room 4 - Discussion Forum

How the unique features of the Tigris vascular stent relate to optimal clinical outcomes: a review of cases

supported with an educational grant from Gore & Associates

Moderator:

Maria Antonella Ruffino
1. 10:00 - 10:05
  
  Introduction
2. 10:05 - 10:13
  
  Case discussion – Radial strength
3. 10:13 - 10:21
  
  Case discussion – Accuracy
4. 10:21 - 10:29
  
  Case discussion – Flexibility
5. 10:29 - 10:37
  
  Case discussion – Fracture resistance
6. 10:37 - 11:00
  
  Discussion and conclusion
Thursday, January 26th: 11:15 - 12:15, Room 4 - Discussion Forum

SYMPOSIUM: Off-the-shelf options to treat challenging aortic anatomies

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert, Giovanni Torsello
1. 11:15 - 11:25
  
  What are the advantages using endoanchors in TEVAR?
2. 11:25 - 11:35
  
  Treatment and embolisation of endoleak TYPE IA and II
3. 11:35 - 11:45
  
  CHEVAR + ONYX: The easy “no-gutters” strategy
4. 11:45 - 11:55
  
  Can we improve the results in EVAR/TEVAR with our current toolbox?
5. 11:55 - 12:05
  
  Type 1A endoleak repair in hostile neck anatomies: Endoanchors can fix it
6. 12:05 - 12:15
  
  Discussion and conclusion
Thursday, January 26th: 12:30 - 13:30, Room 4 - Discussion Forum

THE GREAT DEBATE “Meet the venous experts”: Burning questions in venous interventions

supported with an educational grant from Boston Scientific

Moderator:

Michael Dake
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:43
  
  Do we have enough evidence on the clinical need and benefit of venous interventions?
3. 12:43 - 12:51
  
  Clinical work-up of the venous patient – what is essential?
4. 12:51 - 12:59
  
  What is the optimal techniques for thrombus removal in acute DVT?
5. 12:59 - 13:07
  
  How to best approach chronic venous occlusions?
6. 13:07 - 13:15
  
  What are the features of the ideal venous stent?
7. 13:15 - 13:30
  
  Discussion
Thursday, January 26th: 13:45 - 14:45, Room 4 - Discussion Forum

Antithrombotic treatment in PAD – current status and future perspectives

Moderator:

Rupert Bauersachs, Ulrich Hoffmann
1. 13:45 - 13:53
  
  Is there enough evidence for DAPT after endovascular intervention for PAOD?
2. 13:53 - 14:01
  
  Antiplatlet therapy in PAD – insights from EUCLID
3. 14:01 - 14:09
  
  Lessons learned from the TRA 2°P–Trial–Vorapaxar
4. 14:09 - 14:15
  
  Discussion
5. 14:15 - 14:45
  
  WHAT IS THE HORIZON?
6. 14:15 - 14:23
  
  Update on the EPAD study on Endoxaban
7. 14:23 - 14:31
  
  Update on the Voyager study
8. 14:31 - 14:45
  
  Discussion
Thursday, January 26th: 15:00 - 16:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline: case-based examinations of contemporary aortic issues

Moderator:

Michael Dake
1. 15:05 - 15:12
  
  My algorithmic approach to management of chronic Type B aortic dissection: Technical tips
2. 15:15 - 15:22
  
  Endoleaks post fenestrated and branched endografts: How I assess and treat
3. 15:25 - 15:32
  
  My strategies for evaluation and management of acute IMH: When and how I intervene
4. 15:35 - 15:42
  
  The current best technical practices for parallel branch grafts: How to avoid endoleaks with CHIMPS – When do we cross out of a comfort zone?
5. 15:45 - 15:52
  
  How I deal with thoracoabdominal aneurysms: Contemporary off-the-shelf endovascular considerations

Room 5 - Global Expert Exchange

13 events

Tuesday, January 24th: 10:00 - 10:45, Room 5 - Global Expert Exchange

SYMPOSIUM: Venovo

supported with an educational grant from C. R. BARD

Moderator:

Rick de Graaf

Panel:

Michael Lichtenberg, Stephen Black
1. 10:00 - 10:05
  
  Introduction
2. 10:05 - 10:15
  
  The VERNACULAR trial and clinical experience with the Venovo venous stent
3. 10:15 - 10:25
  
  Experience with the Venovo stent in complicated cases
4. 10:25 - 10:45
  
  Discussion and conclusion
Tuesday, January 24th: 11:00 - 12:30, Room 5 - Global Expert Exchange

CCT@LINC: Japanese art of endovascular treatment: Update

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Keisuke Hirano, Hiroshi Ando, Tatsuya Nakama
1. 11:00 - 11:10
  
  Duplex ultrasound guided wiring for long SFA-CTO lesions: Why we prefer intra-plaque wiring?
2. 11:10 - 11:20
  
  Another advantage of distal puncture: How to cross the un-crossable lesions?
3. 11:20 - 11:30
  
  Aggressive strategy for the treatment of CLI cases: Current status of the below-the-ankle intervention
4. 11:30 - 11:40
  
  New application of CTO crossing device – Crosser: How to treat non-stenting zone using Crosser?
5. 11:40 - 12:20
  
  PRE-RECORDED LIVE CASES OF JAPANESE STYLE EVT
6. 11:40 - 11:50
  
  Case presentation
7. 11:50 - 12:00
  
  Case presentation
8. 12:00 - 12:10
  
  Case presentation
9. 12:10 - 12:20
  
  Case presentation
10. 12:20 - 12:30
  
  Discussion and conclusion
Tuesday, January 24th: 12:30 - 13:30, Room 5 - Global Expert Exchange

The unique advantages of a swirling flow stent: BioMimics 3D

supported with an educational grant from Veryan

Moderator:

Steve Williams

Panel:

Bob Smouse, Gunnar Tepe, Thomas Zeller, Michael Lichtenberg
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:45
  
  How new stent design can improve outcome: the BioMimics 3D story
3. 12:45 - 12:55
  
  Is swirling flow the natural partner to DCBs?
4. 12:55 - 13:05
  
  Clinical evaluation of the swirling flow stent: the MIMICS experience
5. 13:05 - 13:15
  
  The unique advantages of BioMimics 3D: My experience with the swirling flow stent
6. 13:15 - 13:30
  
  Discussion
Tuesday, January 24th: 13:30 - 15:45, Room 5 - Global Expert Exchange

Diabetic patients and critical limb ischemia – Patient specific approaches and novel techniques

partially supported with an educational grant from Alvimedica

Moderator:

Marco Manzi, Dimitrios Karnabatidis

Panel:

Jihad Mustapha, Katja Mühlberg, Michael Edmonds
1. 13:30 - 13:36
  
  Vascular disease location, severity, and progression in diabetic patients
2. 13:36 - 13:42
  
  Infection/ischaemia/amputation: how to build a multidisciplinary center for limb salvage
3. 13:42 - 13:48
  
  The interaction between endo vascular intervention, open surgical arterial bypass, and wound care in the management of 560 patients with diabetic ischaemic foot ulceration
4. 13:48 - 13:54
  
  Time is tissue in critical limb ischemia
5. 13:54 - 14:14
  
  Live case transmission from Berlin
6. 14:14 - 14:20
  
  Outcome of femoropopliteal procedures (stents, DCB, DES) in diabetic patients
7. 14:20 - 14:26
  
  Current developments in SFA treatment and future opportunities
8. 14:26 - 14:46
  
  Live case transmission from Leipzig
9. 14:46 - 14:52
  
  Specifics of BTK arterial disease in diabetic patients and implications for patient specific revascularisation strategies: Which is the right concept – wound-related or total treatment?
10. 14:52 - 14:58
  
  Value of semiquantitative perfusion-CT in critical limb ischemia for perfusion guided revascularisation
11. 14:58 - 15:04
  
  Endovascular techniques for recanalisation of long chronic tibial total occlusions
12. 15:04 - 15:10
  
  Optimisation of angioplasty workflow for CO2-angiography in patients with kidney impairment
13. 15:10 - 15:16
  
  Vessel calcification in BTK arteries: What is specific?
14. 15:16 - 15:22
  
  The latest treatment approach in BTK lesions
15. 15:22 - 15:28
  
  Beside the large vessels – Microvascular disorders in critical limb ischemia
16. 15:28 - 15:34
  
  How should we follow patients with CLI treated with BTK recanalisation
17. 15:34 - 15:45
  
  Discussion and conclusion
Wednesday, January 25th: 8:00 - 10:10, Room 5 - Global Expert Exchange

DEEP DIVE SESSION: Lower limb interventions (part I) – aortoiliac, femoropopliteal and new technologies for crossing, and vessel preparation

Moderator:

Craig Walker, Kazushi Urasawa

Panel:

Miguel Montero-Baker
1. 08:00 - 08:34
  
  Live case transmission from Leipzig
2. 08:34 - 08:52
  
  FOCUS ON AORTO-ILIAC DISEASE
3. 08:34 - 08:40
  
  Use of aortic stent grafts for treatment of aorto-iliac occlusive disease
4. 08:40 - 08:46
  
  12-month results of the BeGraft trial
5. 08:46 - 08:52
  
  Endovascular management of distal embolisation during iliac CTO intervention
6. 08:52 - 09:28
  
  FOCUS ON CROSSING
7. 08:52 - 08:58
  
  We want to know where we are when we treat CTOs: OCT guided revascularisation
8. 08:58 - 09:04
  
  Novel IVUS guided techniques for achieving intra-luminal angioplasty of peripheral CTO lesions – from aortoiliac to below knee lesions
9. 09:04 - 09:10
  
  Mid-SFA as a useful access for complex peripheral interventions
10. 09:10 - 09:16
  
  Recanalisation of flush occlusion of the superficial femoral artery with re-entry device
11. 09:16 - 09:22
  
  U/S guided interventions for complex multi-level lower extremity disease: a vascular surgeon’s effort to significantly reduce procedural radiation exposure
12. 09:22 - 09:28
  
  Vascular Calcium: detection, classification and implications in DCB treatment
13. 09:28 - 10:10
  
  FOCUS ON VESSEL PREPARATION
14. 09:28 - 09:34
  
  Vessel prep is the key to extending the role of DCBs to more challenging lesions and to optimise outcome of stenting
15. 09:34 - 09:40
  
  Angiographic dissection patterns and patency outcomes of post balloon angioplasty for SFA disease (retrospective multicenter analysis)
16. 09:40 - 09:46
  
  Prevention and management of residual stenosis and dissection post popliteal artery dilatation
17. 09:46 - 09:52
  
  Combination therapy of scoring balloons and drug coated balloons as a treatment for instent restenosis
18. 09:52 - 09:58
  
  Bioflex – PEACE registry: Value of different revascularisation strategies before nitinol stent implantation
19. 09:58 - 10:04
  
  Directional atherectomy plus DCB versus DCB alone for isolated lesions of the popliteal artery
20. 10:04 - 10:10
  
  Penumbra for sudden-onset claudication: role of thrombectomy for SFA occlusion
Wednesday, January 25th: 10:10 - 12:30, Room 5 - Global Expert Exchange

DEEP DIVE SESSION: Lower limb interventions (part II) – femoropopliteal, drug-eluting devices, and new technologies

Moderator:

Jos van den Berg, Erich Minar

Panel:

Koen Deloose, Gunnar Tepe, Peter Goverde
1. 10:10 - 12:30
  
  FOCUS ON NEW TECHNOLOGIES, DRUG-ELUTING DEVICES, AND NEW STUDY RESULTS
2. 10:10 - 10:16
  
  Design goals and pre-clinical evidence of next generations DCBs
3. 10:16 - 10:22
  
  Arterial remodeling post DCB: Positive or dangerous?
4. 10:22 - 10:28
  
  All real world DCB studies are not created equal
5. 10:28 - 10:34
  
  Updated clinical trial results for Trireme Chocolate DCB
6. 10:34 - 10:40
  
  Ranger DCB real world registry
7. 10:40 - 10:46
  
  FIRST TIME DATA RELEASE: 1-year results from the Asian subset of the IN.PACT Global Study clinical cohort
8. 10:46 - 10:52
  
  FIRST TIME DATA RELEASE: Insights from the IN.PACT Global Study: The Belgian cohort at 1 year
9. 10:52 - 10:58
  
  FIRST TIME DATA RELEASE: DCB use in the SFA: Budget impact analysis and reimbursement in Austria
10. 10:58 - 11:04
  
  New manufacturing process and stent design are key elements to improve clinical outcome. The iVascular example
11. 11:04 - 11:10
  
  Is lithoplasty followed by DCB the answer in case of calcified vessels?
12. 11:10 - 11:16
  
  Lithoplasty + DCB in calcified lesions – first single center experience
13. 11:16 - 11:37
  
  Live case transmission from Leipzig
14. 11:37 - 11:43
  
  Lessons learnt from DES in the SFA – is there any ideal concept so far?
15. 11:43 - 11:49
  
  DCB + stent in the SFA: 12-month results of the Biolux4ever trial
16. 11:49 - 11:55
  
  The AURORAA registry: 5 year results of the use of the Supera vascular mimetic implant in extensive femoropopliteal lesions
17. 11:55 - 12:01
  
  Meril’s peripheral BRS technologies – Credence BRS and Credence BTK
18. 12:01 - 12:07
  
  Long-term results of TIGRIS-stent angioplasty in popliteal artery lesions
19. 12:07 - 12:13
  
  Impact of chronic total occlusion artery on 5 year adverse events in patients with peripheral artery disease treated by endovascular treatment
20. 12:13 - 12:19
  
  Hybrid treatment for multilevel revascularisation in PAD patients: multicenter study in Korea
21. 12:19 - 12:25
  
  Clinical evidence and gap analysis in intermittent claudication
22. 12:25 - 12:30
  
  Discussion
Wednesday, January 25th: 12:30 - 13:30, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: Clinical experiences on BeGraft peripheral and the NEW BeGraft aortic

supported with an educational grant from Bentley

Moderator:

Piotr Kasprzak

Panel:

Adrien Hertault, Peter Goverde, Johannes Kalder, Sebastian Büchert
1. 12:30 - 12:40
  
  Early experience with 2nd generation Bentley BeGraft peripheral during FEVAR
2. 12:40 - 12:50
  
  First experience in use of NEW BeGraft aortic for covered endovascular reconstruction of the aortic bifurcation (CERAB) and the treatment of extensive aortoiliac occlusive disease
3. 12:50 - 13:00
  
  BeGraft in fenestrated aortic aneurysm repair
4. 13:00 - 13:05
  
  BeGraft aortic in aortic coarctation
5. 13:05 - 13:10
  
  Actual information on BeGraft peripheral and BeGraft aortic
6. 13:10 - 13:30
  
  Discussion
Wednesday, January 25th: 13:30 - 14:15, Room 5 - Global Expert Exchange

Why EKOS? A future of an effective and smart treatment of thrombosis

supported with an educational grant from BTG
1. 13:30 - 13:45
  
  Evidence for USAT in PE patients
2. 13:45 - 14:00
  
  Fast track treatment of PE with the EKOS™ catheter
3. 14:00 - 14:15
  
  More effective than normal CDT, easier than mechanical thrombectomy: my experience with EKOS™ in DVT and PAO patients
Wednesday, January 25th: 14:15 - 17:15, Room 5 - Global Expert Exchange

DEEP DIVE SESSION: Endovenous therapies

Moderator:

Nils Kucher, Ramon Varcoe

Panel:

Gerard O'Sullivan, Erin Murphy, Raghu Kolluri, Stephen Black
1. 14:15 - 14:22
  
  Complete evaluation of the venous patient
2. 14:22 - 14:29
  
  Patient selection algorithm – my imaging modality pathway
3. 14:29 - 14:36
  
  CTV vs. MRV for imaging venous disease
4. 14:36 - 14:43
  
  Deep vein pathology seen with IVUS, what it looks like and what it means!
5. 14:43 - 14:50
  
  The use of adjunctive venography imaging and endovascular maneuvers in the treatment of saphenous vein insufficiency: a prospective, multi-centre study
6. 14:50 - 14:57
  
  IVUS is a better imaging modality than multiplanar venography for assessing and treating iliofemoral venous occlusive disease: lessons from the VIDIO study
7. 14:57 - 15:12
  
  Recorded case presentation
8. 15:12 - 15:19
  
  Dynamics of venous stent design
9. 15:19 - 15:26
  
  VIVO-EU results: Prospective European study of the Zilver vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction
10. 15:26 - 15:33
  
  Iliofemoral venous stenting with the purpose designed VENITI VICI venous stent
11. 15:33 - 15:40
  
  What to do with venous in stent restenosis?
12. 15:40 - 15:47
  
  Vena cava superior syndrom (VCSS) – therapeutic options
13. 15:47 - 15:54
  
  Catheter-directed thrombolysis in acute iliofemoral vein thrombosis, a prospective randomised controlled trial – M. El Maadawy
14. 15:54 - 16:01
  
  Single center randomised study comparing primary stenting and percutaneous transluminal angioplasty for high-grade central venous lesions in the outflow of dialysis fistulas
15. 16:01 - 16:08
  
  How to select patients with deep venous intervention vs. superficial venous intervention in severe venous disease
16. 16:08 - 16:15
  
  Latest technology on laser ablation of varicose veins
17. 16:15 - 16:30
  
  Recorded case presentation
18. 16:30 - 16:37
  
  Endovenous thermal or endovenous chemical ablation – what is the best for the patient?
19. 16:37 - 16:44
  
  VenaSeal clinical overview: Highlights from FIH, eSCOPE and VeClose clinical studies
20. 16:44 - 16:51
  
  WAVES – Lake WAshington Vascular VEnaSeal™ post-market evaluation 3-month results
21. 16:51 - 16:58
  
  The endovascular ablation of incompetent perforator veins using EVLT and RFA
22. 16:58 - 17:05
  
  Foam sclerotherapy and Polidoconol injectable foam for venous ulcerations
23. 17:05 - 17:15
  
  Discussion
Thursday, January 26th: 9:30 - 10:30, Room 5 - Global Expert Exchange

Five unusually challenging fempop cases – What would you have done and how I treated

supported with an educational grant from Abbott Vascular

Moderator:

Larry Diaz-Sandoval, Iris Baumgartner
1. 09:30 - 09:35
  
  Case presentation
2. 09:35 - 09:40
  
  Experts' discussion
3. 09:40 - 09:45
  
  Case presentation
4. 09:45 - 09:50
  
  Experts' discussion
5. 09:50 - 09:55
  
  Case presentation
6. 09:55 - 10:00
  
  Experts' discussion
7. 10:00 - 10:05
  
  Case presentation
8. 10:05 - 10:10
  
  Experts' discussion
9. 10:10 - 10:15
  
  Case presentation
10. 10:15 - 10:20
  
  Experts' discussion
11. 10:20 - 10:30
  
  Summary and conclusion
Thursday, January 26th: 10:30 - 12:30, Room 5 - Global Expert Exchange

Nurse and Technician Forum – Part I

Moderator:

Martin Werner, Koen Keirse
1. 10:30 - 11:31
  
  BASIC TECHNIQUES IN PERIPHERAL INTERVENTIONS
2. 10:30 - 10:38
  
  Step by step: Aortoiliac interventions
3. 10:38 - 10:46
  
  Step by step: How I treat SFA lesions
4. 10:46 - 10:54
  
  Step by step: Infrapopliteal revascularisation
5. 10:54 - 11:02
  
  Stenting in peripheral arteries: Considerations for lesion specific device use
6. 11:02 - 11:10
  
  Step by step: Hybrid procedures for peripheral arterial disease
7. 11:10 - 11:18
  
  Step by step: Abdominal aortic aneurysm: basics of endovascular repair
8. 11:18 - 11:26
  
  Step by step: Carotid stenting – Dos and Don’ts
9. 11:26 - 11:31
  
  Discussion
10. 11:31 - 12:30
  
  ADVANCED TECHNOLOGIES IN PERIPHERAL INTERVENTIONS
11. 11:31 - 11:39
  
  Atherectomy: Data and current developments
12. 11:39 - 11:47
  
  Lithoplasty: A solution for calcified lesions?
13. 11:47 - 11:55
  
  Drug eluting balloons: Update
14. 11:55 - 12:03
  
  Drug eluting stents: New devices
15. 12:03 - 12:30
  
  Discussion
Thursday, January 26th: 12:30 - 13:30, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: Treatment of various aneurysms with multilayer stent MFM

supported with an educational grant from Cardiatis

Moderator:

Ralf Kolvenbach

Panel:

Ivo Petrov, Ricardo Palmeiro Rodrigues, Rupert Portugaller
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:43
  
  Application of MFM technology in complex aortic pathology. Five years experience
3. 12:43 - 12:51
  
  Mechanobiology of the MFM in the treatment of complex thoracoabdominal aneurysm and dissection
4. 12:51 - 12:59
  
  Flow modulation – a new endovascular approach in acute dissections
5. 12:59 - 13:07
  
  Treatment of visceral aneurysms with MFM multilayer stent and outcome
6. 13:07 - 13:15
  
  MFM – what we have learned after 4 years
7. 13:15 - 13:30
  
  Discussion
Thursday, January 26th: 13:30 - 15:00, Room 5 - Global Expert Exchange

Nurse and Technician Forum – Part II

Moderator:

Martin Werner, Koen Keirse
1. 13:30 - 14:31
  
  MISCELLANEOUS
2. 13:30 - 13:37
  
  Venous stenting
3. 13:37 - 13:44
  
  Endoluminal treatment of varicose veins
4. 13:44 - 13:51
  
  Radiation safety
5. 13:51 - 13:58
  
  Complications in the cathlab, and what the team learned from it
6. 13:58 - 14:05
  
  Preplanning a vascular intervention – non-invasive imaging
7. 14:05 - 14:12
  
  Vascular malformations – therapeutic options
8. 14:12 - 14:19
  
  Tasks of a study nurse
9. 14:19 - 14:26
  
  Treatment of complex aneurysm (fenestrated/branched endograft): The Münster Algorithm
10. 14:26 - 14:31
  
  Discussion
11. 14:31 - 15:00
  
  CRITICAL LIMB ISCHAEMIA
12. 14:31 - 14:38
  
  CLI: Optimal care, an interdisciplinary challenge
13. 14:38 - 14:45
  
  Cardiovascular disease in CLI patients
14. 14:45 - 14:52
  
  Diabetic foot syndrome diagnosis and treatment
15. 14:52 - 14:59
  
  Critical limb ischemia: 1-year results of the Critisch registry
16. 14:59 - 15:00
  
  Discussion

Room 6 - Speakers' corner

12 events

Tuesday, January 24th: 12:30 - 13:30, Room 6 - Speakers' corner

Update on peripheral clinical trials and new data – Below the knee/Critical limb ischemia

Moderator:

Jihad Mustapha

Panel:

Miguel Montero-Baker, Steven Kum
1. 12:30 - 12:35
  
  Amputation-free survival between endovascular therapy and bypass surgery in CLI patients: interim analysis of the CRITISCH registry
2. 12:35 - 12:40
  
  Update on the BEST – CLI trial
3. 12:40 - 12:45
  
  Drug-eluting stents versus drug-coated balloons versus plain balloon angioplasty and bare metal stents for the infrapopliteal arteries? An evidence-based approach from a bayesian network meta-analysis
4. 12:45 - 12:50
  
  Lutonix efficacy in BTK: Latest outcomes from the BTK global registry
5. 12:50 - 12:55
  
  Apollo registry trial: below-the-knee angioplasty with paclitaxel eluting balloon catheters in CLI
6. 12:55 - 13:00
  
  The TANGO trial: A phase 2 below the knee study investigating the micropuncture mediated application of Temsirolimus after PTA or atherectomy in CLI patients
7. 13:00 - 13:05
  
  Use of ultrasound to enhance paclitaxel delivery in CLI patients with femoro-popliteal disease: PACUS trial – C. Del Giudice
8. 13:05 - 13:10
  
  LUMINOR registry: a real world experience with a new DEB in advanced limb ischemia
9. 13:10 - 13:30
  
  Discussion
Tuesday, January 24th: 13:30 - 15:10, Room 6 - Speakers' corner

Update on peripheral clinical trials and new data – claudication/femoropopliteal

Moderator:

Erich Minar

Panel:

Ramon Varcoe
1. 13:30 - 13:35
  
  LIBERTY 360 study: Procedural and 30-day outcomes of endovascular interventions in patients with symptomatic lower extremity peripheral arterial disease
2. 13:35 - 13:40
  
  Supervised exercise therapy and peripheral angioplasty: friends or foes? An evidence synthesis from randomised controlled trials
3. 13:40 - 13:45
  
  Morbidity and mortality in PAD-patients – first data from a global prospective multicenter study in claudicants
4. 13:45 - 13:50
  
  Primary stenting of the superficial femoral artery in intermittent claudication gives improved health related quality of life, ABI and walking distance – 12-month results of a prospective randomised multicenter trial
5. 13:50 - 13:55
  
  DOND: Systematic review and meta-analysis on DCB vs. POBA for de-novo femoropopliteal PVD – C. Klumb
6. 13:55 - 14:00
  
  SAVER: rationale and merits for an all comers DCB registry
7. 14:00 - 14:05
  
  CONSEQUENT DCB registry
8. 14:05 - 14:10
  
  EffPac trial: Assessment of the effectiveness of DCB versus POBA in the SFA
9. 14:10 - 14:15
  
  TOBA II and III clinical trial programme
10. 14:15 - 14:20
  
  REALISTIC trial: 18-month results and experiences with the Smart Flex stent for the treatment of femoropopliteal lesions
11. 14:20 - 14:25
  
  First 6-month results in 75 patients in the EVOLUTION study: investigating the iVolution stent in femoropopliteal lesions
12. 14:25 - 14:30
  
  Freeway stent study
13. 14:30 - 14:35
  
  Preliminary data on DRASTICO RCT comparing DCB vs. DES in the treatment of FemPop disease in real world
14. 14:35 - 14:40
  
  FOREST trial: a randomized controlled trial comparing drug-eluting balloons and drug-eluting stents in femoropopliteal arterial occlusive disease – H. Jongsma
15. 14:40 - 14:45
  
  Effectiveness of the Zilver PTX drug-eluting stent for femoropopliteal peripheral arterial disease in patients with no tibial runoff vessels: 24-month results from the Zilver PTX Post-Market Surveillance Study in Japan – S. Cipollari
16. 14:45 - 14:50
  
  REALITY the future of directional atherectomy in the SFA
17. 14:50 - 14:55
  
  2-year follow-up data from the pivotal VISION study for OCT guided directional atherectomy
18. 14:55 - 15:00
  
  Jetstream atherectomy in treating de novo or non-stent restenotic femoropopliteal disease: One-year results from the JET registry
19. 15:00 - 15:05
  
  Treating in-stent occlusions with the Rotarex catheter: the ROBINSON study: final 6-month results in 30 patients
20. 15:05 - 15:10
  
  Discussion
Tuesday, January 24th: 15:30 - 17:00, Room 6 - Speakers' corner

Update on peripheral clinical trials and new data – Carotid/Miscellaneous/EVAR

Moderator:

Peter Schneider

Panel:

Konstantinos Donas, Dai-Do Do
1. 15:30 - 15:45
  
  CAROTID
2. 15:30 - 15:35
  
  CONFIDENCE trial: Nitinol mesh covered carotid stent-trial design and early experience
3. 15:35 - 15:40
  
  SCAFFOLD study: GORE PTFE mesh-covered carotid stent – preclinical and clinical data so far
4. 15:40 - 15:45
  
  Clinical results and mechanical properties of a novel double-layered carotis stent (CGUARD)
5. 15:45 - 16:30
  
  MISCELLANEOUS
6. 15:45 - 15:50
  
  Early results of a prospective registry of carotid stenting with the new C-Guard mesh covered stent in real world: The IRON-GUARD registry – P. Sirignano
7. 15:50 - 15:55
  
  Comparison of different stent models in terms of patency and efficiency in treatment of peripheral artery disease – I. Staudacher
8. 15:55 - 16:00
  
  Covered stents versus bare-metal stents in chronic atherosclerotic gastrointestinal ischaemia (CoBaGI): a multicenter randomised controlled trial – L. van Dijk
9. 16:00 - 16:05
  
  Early clinical experience with the 4 Fr everlinQ™ endoAVF in creating vascular access for hemodialysis: The EASE Study – 4F – T. Berland
10. 16:05 - 16:10
  
  Prevalence of polyvascular disease with aorto iliac artery disease – Results from OMOTENASHI registry – Y .Shintani
11. 16:10 - 16:15
  
  Puncture-site complications in peripheral interventions – a prospective single-center registry of more than 3.000 patients
12. 16:15 - 16:20
  
  PAD meets personalised medicine – O. Aalami
13. 16:20 - 16:25
  
  The effect of renal denervation on blood pressure and sleep apnea – results of the Polish RCT
14. 16:25 - 16:30
  
  The next steps in renal denervation – update on Medtronic SPYRAL HTN program
15. 16:30 - 16:55
  
  EVAR
16. 16:30 - 16:35
  
  Prospective study of the e-liac stent graft system in patients with common iliac artery aneurysm: 30-day results
17. 16:35 - 16:40
  
  INNOVATION: Long-term five year safety and effectiveness of the INCRAFT AAA stent graft for endovascular repair of abdominal aortic aneurysms
18. 16:40 - 16:45
  
  Lessons learned after 200 EndoVascular Aneurysm Sealing (EVAS) procedures – S. Zerwes
19. 16:45 - 16:50
  
  Early and mid-term outcomes of Horizon™ abdominal aortic aneurysm stent graft system – F. Pecoraro
20. 16:50 - 16:55
  
  CURITIBA trial: Custodiol vs. Ringer: what is the best agent for renal protection during toracoabdominal aortic aneurysm open repair? – T. Cambiaghi
21. 16:55 - 17:00
  
  Discussion
Wednesday, January 25th: 9:00 - 10:00, Room 6 - Speakers' corner

Selected abstracts: New techniques and results in iliac and femoropopliteal interventions

Moderator:

Jörn Balzer

Panel:

Peter Goverde, Miroslav Bulvas
1. 09:00 - 09:06
  
  Internal iliac artery angioplasty for the treatment of buttock claudication and erectile dysfunction: a systematic review – K. Patel
2. 09:06 - 09:12
  
  Kissing stenting: Best choice for treatment of common iliac artery chronic obstruction – A. Sonetto
3. 09:12 - 09:18
  
  Management of long flush superficial femoral artery occlusion with ipsilateral antegrade common femoral artery access – A. Aborahma
4. 09:18 - 09:24
  
  The use of boactive stent heliflex in patients with atherosclerotic lesions of superficial femoral artery: the beginning of the study – A. Oleshchuk
5. 09:24 - 09:30
  
  Dissection of the lamina vastoadductoria as a method to reduce the frequency of restenosis in TASC-II D lesions of the femoropopliteal arterial segment after stenting. Intermediate results of the pilot prospective randomised study – A. Rabtsun
6. 09:30 - 09:36
  
  Hybrid heparin-bonded nitinol and ePTFE stent in the treatment of popliteal arrtery occlusion: mid-term follow-up results – J. Wronski
7. 09:36 - 09:42
  
  Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture – K. Ogata
8. 09:42 - 09:48
  
  The safety and efficacy of the distal superficial femoral artery direct puncture technique – T. Takei

Notice

LINC 2017 programme

Room 1 - Main Arena 1

SYMPOSIUM: New evidence for broadened indications using new generation stents in fempop obstructions

Overview of all available stents for use in the SFA/popliteal arteries

Stent design matters – results from a single operator registry

Live case transmission from Leipzig

Advancing medical care in highly diseased patients – the US experience

SUPERFAST – a prospective CTOs registry propensity matched with a historical SNS cohort

The PRESTO technique for precise placement of the SUPERA in the SFA ostium and SUPERSUB update

CFA stenting experiences to date and insights into the CFA SUPERA study

Live case transmission from Dendermonde

Drug-eluting devices for prevention of restenosis – the new standard for femoropopliteal interventions in claudicants

DCB CLINICAL TRIAL UPDATE

Update on 12-month results of the European and US Illumenate RCTs

2-year results of the AcoArt1 – RCT for the use of the Orchid ® DCB in femoropopliteal artery disease

Current status of drug coated balloon treatment in the SFA: What do the 3 year outcomes from the IN.PACT SFA RCT tell us?

A real-world look at treatment effects of IN.PACT Admiral DCB: 12-month results from the IN.PACT Global Study full clinical cohort

FIRST TIME DATA RELEASE: 6-month results of the RANGER RCT – diabetic subgroup

FIRST TIME DATA RELEASE: 12-month results from the MDT-2113 SFA Japan trial – DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA

FIRST TIME DATA RELEASE: DCB: 12-month results of the CONSEQUENT RCT

FIRST TIME DATA RELEASE: The Lutonix EU Long lesion study

FIRST TIME DATA RELEASE: 12-month results of the Illumenate Global Study

FIRST TIME DATA RELEASE: Catheter-mediated deep adventitial microinfusion of dexamethasone for restenosis prevention in femoropopliteal arteries – 12-month results of the DANCE trial

FIRST TIME DATA RELEASE: 2-year results of the REAL-PTX randomised clinical trial comparing Zilver PTX vs. DCB treatment in femoropopliteal lesions

2-year data from the MAJESTIC DES trial for treatment of femoropopliteal disease

DCB + stent in the SFA: 12-month results of the Biolux4ever trial

Patterns of restenosis: a core lab driven assessment of SFA restenosis a potential shift to unify various trials

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease? The REALITY trial

Are drug-eluting devices the new standard for femoropopliteal interventions in claudication?

Discussion

SYMPOSIUM: Drug elution in the SFA: Leave the right thing behind. Debating evidence to provide an answer

Introduction

Why and how to prep the vessel

Live case transmission from Dendermonde

Understanding restenosis in the SFA

The importance of scientific evidence

Live case transmission from Münster

Summing up on symposium

Discussion and debate

Lunch

SYMPOSIUM: Past, present, future: How DCB is enabling treatment of more complex femoropopliteal artery lesions

Introduction

Evolution of DCB technology

Discussion

Live case transmission from Leipzig

IN.PACT drug-coated balloon: Consistent clinical outcomes across patient populations

Discussion

Gain lumen, maintain patency: The power of adjunctive therapy with directional atherectomy and DCB

Discussion

Live case transmission from New York

Conclusion and summary

SYMPOSIUM: Redefining SFA treatment in a drug-eluting world

Introduction and learning objectives

Drug coated balloons – for all or some?

Eluvia drug eluting stent: A platform for success?

Live case transmission from Leipzig

Getting to answers with clinical trials: being bold

Why you should care about health economics in PAD: Funding meaningful innovation

Close and take home learnings

THE LAST FRONTIERS: New concepts for calcified lesions

Patterns of calcification: intimal vs. medial and differences below and above the knee

The Shockwave lithoplasty concept – latest results

Live case transmission from Leipzig

Importance of thorough vessel preparation followed by anti-restenotic therapy: an update from the DEFINITIVE AR study

Treatment of challenging calcified lesions with the next generation. Phoenix atherectomy system

Recorded case

10 steps to percutaneous bypass of extra long, complex SFA occlusions

FIRST TIME DATA RELEASE: The DETOUR trial: Six-month outcomes of percutaneous bypass in long segment femoral-popliteal occlusions

Live case transmission from New York

Discussion

Optimising outcome of BTK interventions in CLI – Current approaches and future outlook

Live case transmission from Leipzig – part I

Prognostic impact of revascularisation in poor-risk patients with critical limb ischaemia: The PRIORITY registry

What have we learned from past DCB BTK studies: Technology, clinical study design, and patient management

Does paclitaxel interfere with wound healing?

How do I treat BTK/CLI with DCB: Past experience and a new beginning

Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug?

The clinical rationale: Why endpoints for CLI trials should be evaluated at 6 months instead of 1 year

Alternative methods of drug delivery: The LIMBO trial